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Introduction & Aims: 
Preterm birth rates have risen to over 8% in Australia. The lungs are one of the last 
organs to develop and therefore, the preterm lung is immature at birth. As effects of 
premature birth on airway cell function are unknown, we investigated whether 




The NECs were obtained via brushing nine preterm born infants (5 males, average 
gestational age at birth 26.6 ± 2.4 weeks) aged 1.7 years corrected age and nine full-
term born infants (5 males) aged 2.3 ± 0.2 years. Submerged monolayer cultures 
were generated and RNA, protein, supernatant and cytospins were collected. Cell 
lineage markers were analysed at gene (qPCR) and protein (immunocytochemistry, 
Western blot) level. Cytokines were measured via ELISA. Two functional assays 
were performed; wound repair by monolayer culture and transepithelial permeability 
assay by differentiated, air-liquid interface culture. 
 
Results: 
Preterm NEC were morphologically similar to full-term NEC as monolayer and ALI 
cultures. Compared to full-term NEC, preterm NECs had significantly higher CK-19 
gene expression at passage 1 (1.95 ± 0.51 vs 0.78 ± 0.17; p<0.05) but not CK-5 and 
vimentin expression. However, CK-19 protein was lower in preterm NECs. Cytokine 
differences were restricted to higher IL-8 by preterm NECs at passage 3 (31587 ± 
3933 vs 15413 ± 5960 pg/mL; p<0.05). Interestingly, transepithelial permeability 
was significantly lower in preterm children for both particle sizes used (4 kDA: 
59.75 vs 324; 20 kDA: 43.26 vs 415.9, p<0.05). Wound repair of preterm NEC was 
also lower (72 hours: 62.10 vs 100%, p<0.05). 
 
Conclusion: 
Preterm and full-term NECs morphology, gene, protein and cytokine expression 
were predominantly comparable at baseline. However, interestingly functional 
iv 
differences also existed. Preterm NECs could be used to model mechanisms of 
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1.1 Introduction  
Global rates of preterm birth are rising with an estimated 11 % of babies born 
preterm each year (1, 2). Infants born at earlier gestational ages, very low birth 
weight infants and infants with respiratory complications are now often surviving 
due to vast improvements in neonatal intensive care (3). Although survival rates 
have increased, preterm births usually have associated consequences which 
contribute to a range of devastating outcomes, including mortality and the chronic 
lung disease of prematurity, bronchopulmonary dysplasia (BPD). This review will 
first discuss normal lung development and the broad range of factors relating to 
preterm birth, before focusing on the literature regarding the aetiology of preterm 
related lung disease and the possible role of the airway epithelium. The aim of this 
review is to identify key gaps in knowledge regarding the airway epithelium of 
preterm born children.   
 
1.2 Lung Development 
Lungs are one of the last organs to develop in utero and therefore are not fully 
developed in a preterm infant. Lung development is a dynamically complex and 
tightly regulated process that spans throughout the gestational period and beyond (4). 
As well as the most critical function of gas exchange, lung tissue must also perform 
mechanisms of innate immunity, mucociliary clearance, and fluid and electrolyte 
transport (4). Throughout the stages of its development in utero and postnatally, the 
lung expands its gas exchange area via branching morphogenesis and alveolarisation 
to maximise gas exchange efficacy (5). Stages of lung development progresses 
through various distinct stages that have overlaps at their ends.  There are six stages 
of lung development: embryonic, psuedoglandular, canalicular, saccular, alveolar 
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and microvascular developmental stages. There is uncertainty as to when lung 
development has finalised, though a recent proposal suggested that lung 
development becomes complete at young adulthood (4, 6).  
 
In the first stage of development, named the ‘embryonic phase’, the lung emerges 
from the ventral wall of the primitive foregut endoderm and proximal structures of 
the respiratory tract is formed from epithelial cells of the foregut endoderm 
migrating to the mesoderm (7) (Figure 1.1). Branching of airways and blood vessels 
continue in the second ‘psuedoglandular stage’ spanning from 7-17 weeks 
gestational age (Figure 1.1). The conducting airways and terminal bronchioles have 
completed forming while still in the process of development are pulmonary arteries 
and veins (7, 8). In addition, epithelial cells start differentiating whilst the 
psuedostratified columnar epithelium is progressively replaced by tall columnar cells 
in proximal airways and cuboidal cells respiratory bronchioles, alveolar ducts and 
rudimentary alveoli; collectively termed acinar structures. Early development of 
pulmonary parenchyma and multiplication of capillaries marks the third ‘canalicular 
stage’ which ranges from 17-27 weeks gestational age (5) (Figure 1.1). The fourth or 
‘saccular stage’ spans from 27-36 weeks gestational age where peripheral airways 
enlarge, acinar tubules dilate giving rise to small saccules and thinning of the walls 
occur resulting in a significant increase in gas exchange area (4, 7, 8) (Figure 1.1). 
Another important hallmark of this stage is the production and secretion of surfactant 
into airspaces (5). Lamellar bodies and surfactant protein can be detected within 
cuboidal type II epithelial cells at 24 weeks gestation (9), though surfactant quality is 
poor. Further differentiation of type I and II epithelial cells occurs in this stage.  
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Alveolarisation mainly occurs in the fifth ‘alveolar stage’, from 36 weeks to 1-2 
postnatal years and encompasses three phases, (i) a first phase where surfactant 
secretion increases and there is formation of new alveolar septa within terminal sacs 
are termed ‘secondary septation’; (ii) a second phase where the formation of a single 
capillary system through remodeling of the capillary network occurs and further 
lengthening and expansion of gas exchange area follows; (iii) a third phase where 
there is overall growth of the lung (4) (Figure 1.1). Whilst up to 50 million alveoli 
are present at the time of birth, most of the alveolar phase takes place postnatally, 
since an adult human lung has approximately 300 million alveoli (10, 11). 
Remodeling of the parenchyma and development of alveolar and capillary networks 
also continues after birth, therefore an infant’s lung post birth is not merely a smaller 
version of an adult’s (5). However, branching morphogenesis does not continue after 
birth (5) . The sixth ‘microvascularisation stage’ takes place in parallel with 
alveolarisation where alveolar septa thins and maturation of microvasculature occurs 
(12). A double layer capillary network is thinned out to a single layered capillary 
network to allow for more efficient gas exchange (12) (Figure 1.1).  
 
Pulmonary vasculature, airway and vascular smooth muscle develop during early 
morphogenesis and all play critical roles in shaping and preparing the lung post 
birth. At term birth, the lung is prepared for gas exchange and its functions post 
birth. Premature infants born between 24-32 weeks gestational age are in the last 
phases of canalicular/beginning phases of saccular stage lung development and are 
minimally prepared for gas exchange. Antioxidant responses to ambient oxygen is 
also still immature and inadequate (7). Thus, disruption to any part of the 
developmental process can result in abnormal lung structure due to 
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underdevelopment, decreased lung function, deficiency of gas exchange and even 
respiratory failure leading to mortality.   
 
1.3 Preterm Infants 
Preterm infants are typically defined as infants born <37 weeks gestational age (2). 
Further definition based on gestational age includes; ‘extremely preterm’ where 
infants are born <28 weeks gestational age, ‘very preterm’ where infants are born 
between 28 to <32 weeks gestational age, and finally, ‘moderate to late preterm’ 
which include infants born between 32 to <37 weeks gestational age (2). A term 
infant is one born from 37-42 weeks gestational age. The worldwide rate of preterm 
birth is rising, with an estimated ~15 million preterm babies born in 2010. More than 
1 million of these children die from preterm-related complications. Within Australia, 
the rate of preterm birth increased from 7.9% in 2003 to 8.6% in 2013 (13). This 
percentage is even higher in indigenous mothers (12.2%) compared to non-
indigenous mothers. The differences in rates or preterm birth are mostly attributed to 
the disparity in antenatal care, with indigenous mothers averaging one less antenatal 
visit than non-indigenous mothers as well as attending these visits later in pregnancy, 
at 15 weeks compared to 13 weeks (13).  
 
Risk factors for preterm birth include; multiple births such as twins and triplets, use 
of in vitro fertilisation and intrauterine infections by bacteria (14-17). Maternal 
wellbeing can also dictate preterm birth to an extent. Factors such as stress during 
pregnancy, being over or underweight and having a pre-existing medical condition 
such as diabetes can contribute to preterm birth. Preterm birth and the associated 
complications pose a considerable burden upon the healthcare system and is also 
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associated with increased healthcare costs (18). A recent population study of very 
preterm infants in Australia showed that 61.6% of admissions to hospital in the first 
12 months post discharge were respiratory related, recording a longer length of stay 
with increasing severity of the respiratory-related condition when rehospitalised (18).  
 
Preterm birth is associated with short and long term consequences. The severity of 
adverse consequences increases with decreasing gestational age and the diagnosis of 
chronic lung disease of infancy, namely BPD. Short and long term outcomes 
affecting quality of life include: respiratory distress syndrome, BPD, gastrointestinal 
system injury, cardiovascular disorders, hearing impairment, retinopathy of 
prematurity and neurodevelopmental problems (19).  
Figure 2.1. Stages of prenatal lung development and branching morphogenesis. 
Modified from http://www.embryology.ch/anglais/rrespiratory/phasen07.html 
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1.4 Respiratory Distress Syndrome (RDS) and BPD 
Infant respiratory distress syndrome begins shortly after preterm birth. It is the most 
common respiratory-related disorder amongst preterm infants and also the single 
most common cause of death within this population in the first month of life (20). A 
decreasing gestational age represents a higher rate of occurrence of RDS while 
incidence can extend to 93% in the extreme preterm cohort (21). Almost 100% of 
preterm children born ≤32 weeks gestational age will have experienced RDS. 
Symptoms of RDS manifest themselves through chest retractions, nasal flaring, 
tachypnea, grunting and increased work of breathing (22, 23). Respiratory distress 
syndrome is primarily caused by an underdeveloped lung and surfactant deficiency 
but can also be caused by excessive fluid in the lung (20, 21). To overcome these 
symptoms, exogenous surfactant, supplemental oxygen (O2), invasive (mechanical 
ventilation) and non-invasive (Continuous Positive Airway Pressure (CPAP)) forms 
of ventilation are given. Infants requiring supplemental O2 for more than 28 days 
before 36 weeks post menstrual age are determined to have the chronic lung disease 
of prematurity, BPD, with severity categorised as mild, moderate or severe 
depending on the concentration of inspired O2 required at this time (24).  
 
Risk factors are often difficult to isolate because there are many interrelationships of 
perinatal and neonatal factors (25). Prenatal risk factors for BPD include, restricted 
intrauterine growth, earlier gestational age, lack of administration of antenatal 
corticosteroids and chorioamniotis and postnatal risk factors are mainly mechanical 
ventilation and supplemental oxygen (25). A sustained exposure to pro-inflammatory 
environmental factors also contributes to BPD in the immature lung (26). 
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Bronchopulmonary dysplasia, also known as chronic lung disease of infancy, is the 
most common respiratory complication that results from extreme premature to very 
premature birth (27). Bronchopulmonary dysplasia was originally described by 
Northway et al. 1967 (28) seen in mature preterm infants (34 weeks gestational age). 
Pathological descriptions were airway injury with some areas of hyper-inflation, 
some areas of severe tissue fibrosis within the lung and flattening of the diaphragms 
(28, 29). Ever since the introduction of surfactant treatment and antenatal steroids 
with the modified application of ventilation strategies appeared, a “new” BPD has 
been described, predominantly affecting infants born <28 weeks gestation (30). The 
new BPD phenotype has been characterised as alveolar simplification, which is the 
presence of fewer larger alveoli resulting in a reduction of gas exchange surface area, 
pulmonary vascular hypoplasia or dysplasia, as well as reduced lung function in later 
life (30, 31). Pathological BPD is further characterised by dysregulated 
vascularisation along with minimal fibrosis of the lung (30, 32).  
 
1.5 Early Life Stressors, Injuries and Treatments 
Infants born prematurely without an established respiratory system usually require 
assistance breathing. Steroids are administered to women expecting a preterm baby 
to help mature the lung whilst in utero. Antenatal corticosteroid administration 
between 24 and 34 weeks gestational age has been shown to be effective in the 
reduction of RDS in infants where there is a high risk of preterm delivery (23). The 
main outcome of antenatal steroid administration is the acceleration of surfactant 
production and lung growth in the foetus (33, 34). As a result of antenatal steroid 
administration, a reduction in adverse consequences associated with preterm birth 
was seen (35). 
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Post birth therapy is personalised and unique to each infant, but typically consists of 
postnatal surfactant therapy, mechanical ventilation, O2 supplementation, and CPAP. 
Treatments like mechanical ventilation and supplemental oxygen are necessary but 
can be injurious to the structure and airway epithelium of the newborn’s lung. 
Exposures to postnatal stressors cause cellular stress, inflammation, disrupted 
alveolar growth and pulmonary vascular development (36). Cellular stressors 
originate from the generation of reactive oxygen species and actual cell injury, 
typically activated by oxygen therapy. Hyperoxic environments relative to the in 
utero environment (~16 %) include supplemental oxygen as well as ambient oxygen 
with an oxygen concentration of 21% (37). The generation of reactive oxidative 
species from hyperoxia-induced injuries without adequate antioxidant defense 
permanently damages proteins, lipids and DNA. Injuries lead to altered cell 
proliferation or cell death (38). 
 
Mechanical ventilation can disrupt lung development leading to an altered lung 
structure. Development disruption consists of arrested alveolarisation, decrease in 
alveoli numbers, and enlargement of airspaces leading to reduction of the lung’s 
internal surface (36, 39). Reduced effective gas exchange areas due to 
underdevelopment and injuries sustained from mechanical ventilation are enough to 
hurt the preterm lung (40). Animal studies have shown that ventilation of the lung to 
almost total lung capacity results in a cascade of cellular injury, inflammation and 
severe lung injury (40). In an injured lung, ventilation to just below normal 
functional residue capacity reported similar outcomes (41). Higher expiratory 
pressures are used to fully facilitate the air expansion of preterm lungs due to 
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fragility, lung rupture may occur (42). Postnatal injuries to lung structure and airway 
epithelium sustained from mechanical ventilation are worsened in the presence of 
other oxidant exposure injuries as well as endotoxins (43). Using the most 
appropriate ventilation method and optimising its administration is beneficial to the 
infant as it protects the lung and decreases risk of unnecessary damage. Patient-
ventilator synchrony is increased, air leakages and days on ventilation are reduced 
(44). Non-invasive therapies are often preferred, though some infants with lung 
disease require invasive ventilation strategies. Rationale for invasive forms of 
ventilation include; apnea from premature birth, poor gas exchange, increased work 
of breathing and the need for surfactant replacement therapy (45). Patient-triggered 
mode of ventilation, namely CPAP, is usually favoured over invasive mechanical 
ventilation as the rates of mortality and morbidity are improved in preterm infants 
(45). Advantages of using this mode of ventilation are lower and consistent 
ventilator pressure with less intracranial pressure, increased patient comfort and less 
sedation in neonates. Less gas trapping and air leaks together with improved 
oxygenation are experienced (45). Invasive forms of ventilation are still important 
and determines the survival of the preterm infant.  
 
Another cause of airway epithelium injury is surfactant deficiency, leading to 
decreased lung compliance. Due to absence of good quality surfactant which allows 
overall uniform expansion, non-uniform expansion of the lung can occur resulting in 
cellular injury (36). Surfactant administration facilitates uniform lung expansion by 
decreasing tension at the air-liquid interface, when given supplemental oxygen and 
minimises lung injury (46). Surfactant increases the survival rate in infants with RDS 
by about 30%, leading to a better prognosis in infants with BPD (47). As highlighted 
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above, there are many post birth stressors that stress airways and lungs of the 
preterm infant. Effects from these injuries can be long lasting halting lung 
development. Succeeding lung injuries are accompanied by reduced and abnormal 
pulmonary function. 
 
1.6 Pulmonary Outcomes and Long Term Consequences 
As a result of an immature lung coupled with mechanical ventilation and 
supplemental oxygen, preterm infants have susceptibilities to reduced lung function 
and various other respiratory consequences due to the altered lung structure 
throughout life. Clinical studies have shown respiratory consequences including 
chronic and recurrent coughing and wheezing, bronchial hyperreactivity and 
increased incidence of pneumonia and bronchiolitis to be consistent with preterm 
birth (48, 49). Prematurely born children are commonly found to have structural 
abnormalities within the lung, as highlighted by Simpson et al. 2017 where 92% of 
preterm born children (≤32 weeks gestational age) in the study had altered lung 
structure (50). Specifically, children with structural lung abnormalities had impaired 
lung function with obstructive lung disease evident in those with more extensive 
abnormality (50). 
 
Impaired lung function is also detectable within the first few months of life and 
persists through childhood (49). Freidrich et al. 2007 reported preterm children born 
between 30-34 weeks gestational age had decreased airway function that was 
experienced up to the second year of life (51). These preterm children experienced 
decreased forced expiratory flows despite having similar forced vital capacity 
volumes as the controls. Explanations for this observation were attributed to a 
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decrease in pulmonary elastic recoil secondary to abnormal alveolarisation and more 
compliant airways or that preterm infants have a normal sized lung but significantly 
smaller airways (51). There is a higher prevalence of BPD diagnosed preterm infants 
suffering impaired lung function and increased respiratory morbidity that persists 
into middle childhood (52-54). Respiratory morbidity in later life is typically 
indicated by the severity of neonatal lung disease (53). Several studies have 
demonstrated that preterm children diagnosed with BPD have abnormal and reduced 
lung function later on in life attributed to lung injuries and arrested development 
experienced in early life (50, 54). A recent study has shown that BPD survivors with 
the new BPD phenotype experience lower lung function in late adolescence with 
potential continuous lung function decline (55).  
 
1.7 Airway Epithelial Cells 
Very preterm infants are born before completed lung development and consequently 
maturation of airway epithelial cells is incomplete. Every day, airway epithelial cells 
play an essential functional role by maintaining the airway conduit. Airway epithelial 
cells are responsible for the defense of the lung against inhaled pollutants and 
irritants (56). The airway epithelium is a continuous layer of cells that cover the 
bronchial tree and functions as an interdependent unit with other lung components 
(56). The cell types that line the airways and alveoli include ciliated, mucous, 
secretory and basal cell types (57). They function to; transport gases to and from the 
alveoli; act as a physical barrier; assist in mucociliary clearance; produce 
antimicrobial peptides, proteins, reactive oxygen and nitrogen species; and secrete 
cytokines, chemokines and growth factors (58). Besides its traditional barrier role, 
the airway epithelium is now thought to be central in the orchestration of innate and 
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adaptive immune responses in lung related diseases. Long term immune activation 
such as clearance of mucous, production of lytic enzymes and mucins, lysozymes 
and type I and III interferons, as seen in the context of chronic inflammatory disease 
is driven by airway epithelial cells (57, 59). Airway epithelial cells’ recognition of 
inhaled pathogens are through Toll-like receptors and oligomerization domain-like 
receptors which leads to the production of anti-microbial and pro-inflammatory 
cytokines (60). These cells also recruit immune cells including natural killer cells, T 
cells, neutrophils, innate lymphoid cells and M2 macrophages. 
 
Abnormalities in the repair process by airway epithelial cells can result in life long 
changes like those seen in the clinical phenotype of asthma where tissue remodeling 
is typically observed. For example, wound repair processes are initiated via the 
inhalation of injurious stimuli from the external environment, such as mechanical 
ventilation and supplemental O2. In addition, the endotrophic mesenchymal unit, 
which accounts for the cell-to-cell interactions between airway epithelial cells and 
mesenchymal cells can lead to remodeling of airway tissue. Cell interactions occur 
through growth factors and cytokines that promote inflammation and tissue 
remodeling (60).  
 
The airway epithelium acts as a barrier to inhaled particles and pathogens, 
preventing their contact with underlying cellular tissue. A system of apical tight 
junctions, adherens junctions and hemidesmosomes form the luminal junction 
complex (61). These junctional complexes between neighbouring cells are the main 
regulators of paracellular permeability and ion/solute movement between cells. 
Disruption of tight junctions results in loss of barrier integrity, with a ‘leaky’ 
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epithelium facilitating pathogens transfer and increasing the predisposition to airway 
infection (Figure 2) (57, 60, 61). Primary airway epithelial cells derived directly 
from patients are an indispensable research tool. Access to bronchial brushings in the 
preterm cohort is very limited due to the invasive nature of sampling. This ethical 
limitation limits sampling in vulnerable cohorts like infants, younger children and 
those with disease.  
 
Figure 1.2. 'Leaky' epithelium portraying pathogens infiltrating past airway 
epithelium barrier. 
 
1.7.1 Immortalised Cell Lines 
Immortalised cell lines are a valuable tool when access to primary cells are limited. 
They are also used as experimental tools for standardisation, optimisation and 
comparison (62, 63). Immortalised cell lines are typically generated via the 
introduction of oncogenes with or without human telomerase reverse transcriptase 
(hTERT), or by gene expression that suppresses senescence (63). There are several 
advantages using immortalised cell lines including: large cell yields that could be 
easily adapted for high throughput screening. They are also cost effective and 
convenient to use. Although, the viral oncogene combined with hTERT approach 
produces an aneuploid cell line that escapes the senescence stage of cell development 
and is rapid growing, remaining genetically unstable. Significantly, after continuous 
passage, immortalised airway epithelial cells have been shown to lose the ability to 
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undergo mucociliary differentiation or polarise (63, 64), a key characteristic of 
airway epithelium. An undefinable amount of mutations arising from continuous 
replications may have been attained by the immortalised cell (63).  Immortalised cell 
lines allow for rapid expansions but accumulate spontaneous mutations through 
serial passaging. This alters lineage characteristics and limits the amount of data that 
can be interpreted the use of immortalised cells. Therefore in many research settings 
of disease phenotypes, primary cells are still the preferred model. 
 
1.7.2 Primary Tissue Derived Cells 
Primary cells are those isolated directly from human or animal tissue. Being obtained 
from the body, cells established will exhibit no alterations in genotype and 
phenotype will be most reflective of the in vivo setting. These cells can be derived 
from two sources; (1) live sources, which typically originate from ethically-approved 
study participants and (2) deceased sources, typically cadaver-derived. 
Commercially available primary cells from healthy and disease settings are now 
more readily accessible and can be easily purchased adding to the list of advantages 
(65, 66). Primary cells collected straight from a test participant has many benefits 
including access to essential information including birth details and full medical 
history. However, the biggest advantage is knowing these cells have not been 
manipulated therefore are a truer reflection of their in vivo counterparts. In certain 
research settings, specifically paediatrics, there is a need to use primary cells 
obtained directly from study participants. Most immortalised cell lines and 
commercially available primary cells have been obtained predominantly from adults 
and none from young children, specifically infants (58). Primary cells are not 
immortal and will not proliferate indefinitely unless modified with a viral oncogene. 
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Limited expansion potential is thus the major shortcoming of primary cells. 
Modification with hTERT, allows expansion of primary cells similarly to an 
immortalised cell line producing high yields of cells. This may prove to be beneficial 
as well as a disadvantage as cells have been altered and may not be reflective of their 
in vivo counterparts. Disadvantages of commercially purchased primary cells are 
their expense and inability to stratify according to particular parameters including 
age, gender and specific conditions, such as BPD. Furthermore, the absence of any 
medical history of the donor can limit their application.  
 
A recent significant advancement had meant that the limitations associated with 
primary airway epithelial cells, namely slow expansion rates and fragility in culture, 
have been addressed (67). Importantly, emerging data suggests that conditionally 
reprogrammed airway epithelial cells maintain morphology, lineage characteristics 
and disease specific function over several passage (67). The methodology involves 
co-culturing primary airway cells with an irradiated fibroblast cell feeder layer, in 
medium that contains Rho-associated kinase (ROCK) inhibitor, which increases cell 
population doubling by shortening the cell’s telomerase (67). Both healthy and 
diseased states have been found to proliferate under these conditions whilst still 
maintaining phenotype specific characteristics over extended passage, allowing for 
high cell yields (67). Cellular and lineage characteristics assessed included: 
cobblestone morphology maintenance throughout the life of every culture and 
unchanged epithelial lineage at both gene and protein levels (67). It has also been 
shown utilising air-liquid interphase cultures that conditionally reprogrammed 
airway epithelial cells are capable of fully differentiating into stratified epithelium, 
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with differentiated cell types still maintaining their lineage (including disease) 




1.7.3 Airway Epithelial Cells of Preterm Infants 
Despite advances in the field, detailed characterisation of the airway epithelium in 
preterm infants has not been performed. Particularly, the function of the airway 
epithelial cells has not been studied and thus it remains unknown whether there are 
any intrinsic differences in these cells when compared to healthy term airway 
epithelium. There is anecdotal evidence to attest the fragility of the preterm airway. 
Particularly, evidence exists that these infants are more susceptible to viral infections 
and can be severely affected leading to long periods of hospitalisations and multiple 
readmissions especially in the first year after birth (68). This increased susceptibility 
may be due to intrinsic epithelial defects, however, this remains to be determined. To 
date, studies that have characterised paediatric airway epithelial cells in health and 
disease have been done using cells from older full-term children (69, 70). Although 
tracheal cells are preferred since they reflect cells of the lower airway, the invasive 
nature of sampling precludes their obtainment from infants collectively. However, 
access and sampling the nasal passage of preterm infants when stable, is an 
acceptable and utilised approach.   
 
Procurement of nasal epithelium involves a minimally invasive method and is 
preferred for infants (71). An investigation comparing nasal and lower airway 
epithelial cells showed that nasal airway epithelial cells are comparable to their 
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lower airway counterpart (72). Specifically, the authors found little differences at 
baseline in a panel of cytokines and absolute mediator levels measured (72). Of 
importance, immunostaining for cytokeratin-19 stained positive in both nasal and 
bronchial cells confirming epithelial lineage (72). Via the use of light and electron 
microscopy, nasal and bronchial cultures also had comparable cobblestone 
morphology (72). In response to stimulation with proinflammatory cytokines; IL-1β 
and TNF-α, levels of stimulated mediators; IL-8, IL-6, RANTES, MMP-9 were all 
significantly produced by both cultures. Though absolute, constitutive and stimulated 
mediator levels were different, the magnitude of response from the nasal and 
bronchial airway epithelial cells were similarly exhibited (72). Similar expression of 
relevant receptors for adhesion molecules and integrins in nasal and bronchial airway 
cells were observed (72). These initial observations have been corroborated by 
another study that observed similarities in cell morphology, growth characteristics 
and ciliary activity between nasal and bronchial epithelial cells (73).  
 
1.8 Hypotheses and Aims 
There is very little understanding of the airway epithelial cells in preterm infants and 
whether or not they function as expected compared to their full-term counterparts. 
Preterm infants are born whilst their lungs are still significantly underdeveloped 
including the airway epithelium. The fragility of the preterm airway is typified by the 
fact that they are more susceptible to viral infections that increase in severity with 
the level of prematurity. Preterm infants are also known to have impaired lung 
structure and function as well as persisting respiratory symptoms such as wheeze 
well beyond their infant years. This decline in lung function may be indicative of an 
active disease process including inflammation or airway remodeling, however there 
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is very little evidence directly connecting the airway epithelium with altered function 
and long term effects. Furthermore, little is known whether any change in the airway 
epithelial cells at time of preterm birth are transitory or become intrinsic to the 
airway contributing to the long term effects seen in the lungs of these children.  
 
Therefore, this study hypothesises that:  
• Nasal epithelial cells of very preterm infants (≤32 weeks gestational age) are 
biochemically and functionally different to their full-term counterparts. 
The hypotheses will be tested via three aims: 
• Characterisation of nasal cells of preterm born infants and healthy full-term 
born infants 
• Assessment of potential lineage, biochemical and functional differences 
between the preterm and healthy cohorts 
• Assessment of lineage, biochemical and functional differences over passage 
between preterm and full-term infants 
 
The elucidation of characteristics and functionality of preterm airway epithelial 
cells will be a valuable insight into understanding the mechanisms of lung-
related preterm diseases. It will set a baseline reference for future studies by 
possibly proving that airway epithelial cells of preterm infants are intrinsically 















Materials & Methods  
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This chapter provides detailed properties or instructions for the materials and 
methods that are common to all chapters of this thesis. 
 
2.1 General Materials 
Material name, Supplier, Supplier’s origin (City/Town; State/County, Country) 
0.22 μM filter, Merck Millipore, Carrigtwohill, Co. Cork, Ireland 
25G & 27G needles, Terumo, Macquaire Park, NSW, Australia 
2-β-Mercaptoethanol, Sigma, St. Louis, MO, USA 
2mM deoxyribonucleotide triphosphates (dNTPs), Applied Biosystems, Foster City, 
CA, USA 
4’,6-diamidino-2-phenylindole (DAPI), Sigma, St. Louis, MO, USA 
4-(2-hydroxyethyl1)-1-piperazineethanesulfonic acid (HEPES), Sigma, St. Louis, 
MO, USA 
10X RT-buffer, Applied Biosystems, Foster City, CA, USA 
Adenine suitable for cell culture, Bioreagent, Sigma, St. Louis, MO, USA 
Acetone, Sigma, St. Louis, MO, USA 
Bovine pituitary extract (BPE), Sigma, St. Louis, MO, USA 
Bovine serum albumin (BSA), Sigma, St. Louis, MO, USA 
Bronchial epithelium basal medium (BEBM), LONZA™, Basel, Switzerland 
Calcium chloride (CaCl2), Sigma, St. Louis, MO, USA 
Cholera toxin from Vibrio cholerae, Sigma, St. Louis, MO, USA 
Citric acid, Sigma, St. Louis, MO, USA 
Collagen from Rat Tail (Type 1), Life Technologies, Carlsbad, CA, USA 
Cryovials, Nunc, Roskilde, Denmark 
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Dimethyl sulfoxide (DMSO), Sigma, St, Louis, MO, USADulbecco’s Modified 
Eagle Medium-High Glucose (DMEM-HG), Invitrogen, Melbourne, VIC, Australia 
Enhancement Solution, PerkinElmer, Waltham, MA, USA 
Epidermal Growth Factor (EGF) recombinant human, Sigma, St. Louis, MO, USA 
Ethanol (Absolute), LOMB Scientific, Taren Point, NSW, Australia 
Fibronectin, Sigma, St. Louis, MO, USA 
Foetal Calf Serum (FCS), Sigma, St. Louis, MO, USA 
Formalin, Sigma, St. Louis, MO, USA 
Fungizone, Invitrogen, Melbourne, VIC, Australia 
Gentamicin, Invitrogen, Melbourne, VIC, Australia 
Glacial Acetic Acid, ChemSupply, Gillman, SA, Australia 
Ham’s F-12 Nutrient Mixture, Gibco, Malaga, WA, Australia  
Human Epidermal Growth Factor (EGF) ELISA, elisakit.com, Melbourne, VIC, 
Australia 
Hydrochloric Acid (HCl, 33%), Univar, Ingleburn, NSW, Australia 
Hydrocortisone, Sigma, St. Louis, MO, USA 
Insulin, Sigma, St. Louis, MO, USA 
Li-Cor Odyssey Blocking Buffer, LI-COR Biosciences, Lincoln, NE, USA 
Magnesium Chloride (MgCl2) Sigma, St. Louis, MO, USA 
Methanol, Analytical Sciences, Patumwan, Bangkok, Thailand 
Micro BCA Protein Assay Kit, Thermo Fisher Scientific, Scoresby, VIC, Australia 
Mycoplasma-Off, Minerva-Biolabs, Berlin, Germany 
Nalgene Mr Frosty, Wessington Cryogenics, Houghton-le-Spring, Tyne & Wear, 
England 
Parafilm, Bacto Laboratories, Mt Pritchard, NSW, Australia  
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Penicillin Streptomycin (Pen/Strep), Invitrogen, Melbourne, VIC, Australia 
Potassium Chloride (KCl), Sigma, St. Louis, MO, USA 
Potassium Phosphate Monobasic (KH2PO4), BDH Lab. Supplies, Poole, Dorset, 
England 
Protease Inhibitor Cocktail, SIGMA, St. Louis, MO, USA 
Proteinase K, Sigma, St. Louis, MO, USA 
Random Hexamers, Applied Biosystems, Foster City, CA, USA 
ReagentPack Subculture Reagents, Lonza™, Basel, Switzerland 
Retinoic Acid, Sigma, St. Louis, MO, USA 
RLT Buffer, QIAGEN, Chadstone Centre, Victoria, Australia 
RNase Free Water, Applied Biosystems, Foster City, CA, USA 
RNase Inhibitor, Applied Biosystems, Foster City, CA, USA 
ROCK Inhibitor, Enzo Life Sciences, Farmingdale, NY, USA 
RPMI-1640 Media, Invitrogen, Melbourne, VIC, Australia 
Sodium Carbonate (Na2CO3), Sigma, St. Louis, MO, USA 
Sodium Chloride (NaCl), Sigma, St. Louis, MO, USA 
Sodium Hydrogen Carbonate (NaHCO3), Sigma, St. Louis, MO, USA 
Sodium Hydroxide (NaOH), Sigma, St. Louis, MO, USA 
Sodium Phosphate Dibasic (Na2HPO4), BDH Lab. Supplies, Poole, Dorset, England 
StarFrost® Advanced Adhesive Slides, Waldemar Knittel, Braunschweig, Germany  
Sudan-Black B, Sigma, St Louis, MO, USA 
Syringe (1 mL), Terumo, Macquaire Park, NSW, Australia 
SYBR Green, Life Technologies, Mulgrave, VIC, Australia 
Trans Retinoic Acid, Sigma, St. Louis, MO, USA 
Transferrin Powder, Sigma, St. Louis, MO, USA 
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Tri-iodothyronine, Sigma, St. Louis, MO, USA 
Trypan-Blue Solution, Sigma, St. Louis, MO, USA 
Trypsin, Sigma, St. Louis, MO, USA 
Trypsin-Ethylenediaminetetraacetic Acid (T-EDTA) Solution, Sigma, St. Louis, 
MO, USA 
Tween-80, Sigma, St. Louis, MO, USA 




Glasswares were autoclaved using an Atherton autoclave (Melbourne, VIC, 
Australia). 
Balances 
An A&D Weighing GR-300 lab balance was used to measure all reagents (Adelaide, 
SA, Australia). 
Centrifuges 
All centrifugation was performed using an Eppendorf 5810R refrigerated Swinging-
Bucket Rotor and 5415D mini-centrifuge (Hamburg, Germany). Cytospin 
centrifugation was performed using a Hettich® ROTOFIX 32A centrifuge 
(Tuttlingen, Baden-Württemburg, Germany). 
Incubators 
Cell cultures were housed in a Panasonic incubator (Gunma, Japan) with an 





Membranes were scanned and analysed on the Li-Cor Odyssey infared scanner (LI-
COR Biosciences, Lincoln, NE, USA). 700nm and 800nm wavelengths were used 
for scanning as required.  
Laminar Flow Cabinets 
Cell culture work was performed in a Laminar Flow Cabinet from AES 
Environmental (Balcatta, WA, Australia) certified by the National Association of 
Testing Authorities. 
Live Cell Imaging System 
Live cell cultures were imaged when needed in the IncuCyte® ZOOM System 
(ESSEN Bioscience, Ann-Arbor, MI, USA). 
Microscope 
To study cell morphology and viability, a Leica Microsystems inverted microscope 
(Wetzlar, Hesse, Germany), or using a Nikon R Eclipse Ti inverted microscope with 
an attached Nikon camera and digital imaging system (Coherent Scientific, Hilton, 
SA, Australia) were used. 
pH Meter 
All pH calibrations and measurements were obtained using a Jenway 3310 pH meter 
(Stone, Staffordshire, England), and calibration solutions were obtained from 
Scharlau (Barcelona, Catalonia, Spain). 
Pipettes 
Gilson micropipettes (Middleton, WI, USA) and Eppendorf micropipettes 
(Macquarie Park, NSW, Australia) were used to measure volumes less than 1ml. 
Volumes between 1-25ml were measured using a Thermo Fisher Scientific Matrix 




Plates were read on a Thermo Fisher Scientific Multiskan FC Microplate Photometer 
(Scoresby, VIC, Australia), EnSpire® Multimode Plate Reader (PerkinElmer, 
Waltham, MA, USA) and ClarioStar (BMG Labtech, VIC, Australia) 
Real Time Quantitative PCR (RT-qPCR) 
Reverse transcription of RNA into cDNA was conducted using an MJ Research 
PTC-100 Thermal Cycler (Boston, MA, USA). RT-qPCR was performed on cDNA 
using an Applied Biosystems ABI Prism 7700 (Foster City, CA, USA). Software 
programs Sequence Detection System 1.9 and Microsoft Excel (Redmond, WA, 
USA) were used for data analysis. 
Tissue Culture Plasticware 
All disposable tissue culture plasticware was obtained from BD Biosciences 
(Franklin Lakes, NJ, USA) and Eppendorf (Macquarie Park, NSW, Australia). 
Semi-dry Western Blot Transfer 
The iBlot system by Invitrogen (Melbourne, VIC, Australia) was used for semi-dry 
transfer of protein bands from previously electrophoresed gel. A ‘TOP’ stack 
consisting of a copper cathode, ‘BOTTOM’ stack consisting of a copper anode, 
sponge and PVDF membrane were used to facilitate the transfer.   
Solution Agitation 
A variety of equipment was used to mix or agitate solutions including a shaker 
(Ratek, Boronia, VIC, Australia), vortex (IKA, Guangzhou, China), magnetic heated 
stirrer (Industrial Equipment and Control Pty Ltd, Thornbury, VIC, Australia), 
sonicator (UniSonics, Brookvale, NSW, Australia) or rocker (Stuart, Bibby 




Samples and reagents were thawed or warmed using a Thermoline Water Bath 
(Smithfield, NSW, Australia) when required. 
Western Blot 
Gels were ran in a Novex BOLT™ Apparatus chamber (ThermoScientific). 
 
2.3 General Buffers and Solutions 
Double Deionised Water (ddH2O) 
Distilled water was passed through a Mill-Q water purification system (Millipore, 
North Ryde, NSW, Australia) to obtain ddH2O. 
 
70% (v/v) Ethanol 
To make 1000ml of 70% (v/v final) solution of ethanol, 700ml of absolute ethanol 
was added to 300ml of ddH2O and stored at room temperature until required. 
 
80% (v/v) Ethanol 
To make 1000ml of 80% (v/v final) solution of ethanol, 800ml of absolute ethanol 
was added to 200ml of ddH2O and stored at room temperature until required. 
 
Carnoy’s Solution 
To make 100ml of Carnoy’s solution, 10ml of glacial acetic acid, 30ml of 
chloroform and 60ml of ethanol were added together. For use, the solution was ice 
cold and used within 24 hours of preparation.  
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Cell Protein Extraction Buffer (CEB) 
To make 100ml of CEB, 0.59g of 100mM NaCl, 0.037g of 1mM EDTA, 0.038g of 
1mM EGTA, 0.892g of 20mM Na4P2O7, 100 μl of 1mM NaF, 1ml of 2mM Na3VO4 
and 1ml of Tris (pH 6.8) was made up to 80ml with ddH2O and the pH was adjusted 
to 7.4 with HCl. After the pH was adjusted, 1ml of 1% Triton X-100, 10ml of 10% 
glycerol, 500μl of 0.1% sodium dodecyl sulfate (SDS) and 5ml of 0.5% sodium 
deoxycholate was added into the solution. The final volume was made up 100ml and 
stored at -20°C until required for use.  
 
HEPES Buffered HBSS Solution 
To make 1000ml, 0.35g of NaHCO3 and 5.96g of 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) was dissolved in 1000ml of HBSS. The pH 
of the solution was adjusted to 7.4. The solution was autoclaved if required and was 
stored at 4°C until required.  
 
3-[4,5-dimethylthiazol-2yl]-5-[3-carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-
tetrazolium inner salt (MTS)/PMS Solution 
A 20ml aliquot of MTS solution and PMS solution was thawed at either room 
temperature for about 90 minutes or at 37°C for 10 mins. 1ml of PMS solution was 
added to 20ml of MTS solution mixed via pipetting and then aliquoted into a yellow 
capped tube. The MTS/PMS solution was stored at -20°C.  
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Neutral Buffered Formalin (NBF) 
To make 1000ml, 900ml of ddH2O was combined with 100ml of formalin together 
with 4g of NaH2PO4 and 6.5g of NaH2PO4. Storage of the solution was in 4°C until 
required for use.  
 
Phosphate Buffered Solution (PBS) 
To make 1000ml of 10x PBS, 80g of NaCl, 2g of KCl, 14.4g of NaH2PO4 and 2.4g 
of KH2PO4, were combined and dissolved in 1000ml of ddH2O. A magnetic stirrer 
was used facilitate dissolving of the reagents and solution was then calibrated to pH 
7.0. The solution was autoclaved for sterile use. For 1x PBS, 1 part of 10x PBS was 
diluted into 9 parts of ddH2O for use. 
 
Quenching Solution 
To make 500ml, 2.5g of Sudan Black B was added to 500ml of 70% (v/v) ethanol 
and stored at room temperature until ready for use. 
 
RLT Lysis Buffer 
To make 50ml of RLT lysis buffer, 500μl of 2-mercaptoethanol was added to 50ml 
of lysis buffer from QIAGEN. The solution was stored at room temperature until 
required for use.  
 
ROCK Inhibitor 
To make 2.5mg/ml of ROCK inhibitor solution, 25mg of ROCK inhibitor was 
dissolved in 10ml of ddH2O. The solution was stored at -20°C until required for use. 
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Tris Buffered Solution (TBS) 
To make 1000ml of 10x TBS, 80g of NaCl, 2g of KCl and 30g of Trizma Base were 
dissolved into 1000ml of ddH2O with the assistance of a magnetic stirrer. The 
solution was then calibrated to pH 7.4, autoclaved and stored at room temperature. 
For 1x TBS, 1 part of 10x TBS was diluted in 9 parts of ddH2O for use. 
 
Zuk’s Blocking Buffer 
To make 1000ml, 5g of BSA, 1g of Saponin, 100μl of Triton x-100 and 10ml of FCS 
was added to 890ml of 1x PBS/TBS solution. 
 
2.3.1 Cell Culture Solutions 
1:2 T-EDTA 




To make 50ml, 12.5ml of T-EDTA was added to 37.5ml of 1x PBS solution and 
mixed well.  
 
1:100 T-EDTA 
To make 50mL, 500μl of T-EDTA was added to 49.5ml of 1x PBS solution and 




16HBE14o- Culturing Media 
To make 100ml of 16HBE14o- culturing media, 10ml of FCS, 1ml of Pen/Strep and 
1ml of Glutamax were added to 89ml of MEM. Media solution was stored at 4°C 
until required for use. 
 
16HBE14o- Cryopreservation Medium 
Cryopreservation medium ratios are; 90% (v/v final) 16HBE14o- media and 10% 
(v/v final) DMSO. One ml of cryopreservation medium was made using 900μl of 
FCS and 100μl of DMSO.  
 
Bronchial Epithelial Growth Medium (BEGM) 
To make 500ml, 25μg/ml of bovine pituitary extract, 0.5μl/ml of hydrocortisone, 
0.025μg/ml of epidermal growth factor, 0.5μg/ml of epinephrine, 0.0065μg/ml of tri-
iodothyronine, 5μg/ml of insulin, 10μg/ml of holotransferrin bovine, 0.0001μg/ml of 
retinoic acid, 50μg/ml of gentamycin, 1% (v/v final) of penicillin, 1% (v/v final) of 
streptomycin and 1% (v/v final) of fungazone was added first to 5ml of Bronchial 
Epithelial Basal Medium (BEBM) and filter sterilised then added to 495ml of 
BEBM. The solution was filter sterilised, aliquoted into 50ml tubes and stored at 4°C 
until required for use. 
 
Co-culture Media (CCM) 
To make up 500ml, 5% (v/v final) of FCS, 0.0004mg/ml of hydrocortisone, 
0.005mg/ml of insulin, 0.01μg/ml of epidermal growth factor, 0.0084μg/ml of 
cholera toxin, 0.024μg/ml of adenine, 0.0025mg/ml of ROCK inhibitor and 0.1% 
(v/v final) of penicillin/streptomycin was added to a base mix of 156.7ml of DMEM 
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(High Glucose + L-Glut) and 313.3ml of F12. The solution was filter sterilised, 
aliquoted into 50ml tubes and stored at 4°C until required for use.  
 
Collection media for primary cells 
To prepare collection media, 4ml of RPMI and 1ml of FCS were added together into 
a tube and stored at 4°C until required for use.  
 
Cryopreservation Medium for NIH-3T3 
Cryopreservation medium ratios are; 70% (v/v final) NIH-3T3 media, 20% (v/v 
final) HI-FCS and 10% (v/v final) DMSO. 1 ml of NIH-3T3 cryopreservation 
medium was made using 700μl of NIH-3T3 media, 200μl of HI-FCS and 100μl of 
DMSO.  
 
Cryopreservation Medium for Primary Cells 
Cryopreservation medium ratios are; 90% (v/v final) FCS, 10% (v/v final) DMSO 
and 1μl /ml of ROCK inhibitor. 1ml of cryopreservation medium was made using 
900μl of FCS, 100μl of DMSO and 1μl of ROCK inhibitor. 
 
Fibronectin Coating Buffer for Primary Cell Culture 
To make up 100ml, 1mg of fibronectin was diluted in 10ml of BEBM at 37°C for 1 
hour. One ml of type IV rat tail collagen and 10ml of BSA was then added and 
volume made up to 100ml with BEBM. The solution was then filter sterilised and 
stored at 4°C until required for use. Fibronectin coating buffer was reused up to 3 
times prior to discarding. 
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NIH-3T3 Culture Media: 
To make 50ml of NIH-3T3 media, 5ml of HI-FCS and 500μl of penicillin-
streptomycin was added to 45ml of Dulbeco’s Modified Eagle Medium (DMEM) 
media. Solution was then stored in 4°C until required for use.  
 
Air-liquid Interface Media 
Media consisted of a 1:1 mixture of 1x LHC medium and DMEM supplemented 
with, 0.5mg/ml of bovine serum albumin, 25μg/ml of bovine pituitary extract, 
0.5μl/ml of hydrocortisone, 0.025μg/ml of epidermal growth factor, 0.5μg/ml of 
epinephrine, 0.0065μg/ml of tri-iodothyronine, 5μg/ml of insulin, 10μg/ml of 
holotransferrin bovine, 0.0001μg/ml of trans-retinoic acid, 50μg/ml of gentamicin, 
0.5μM of phosphorylethanolamine, 0.5μM of ethanolamine, 3μM of zinc sulfate, 
1.5μm of iron II sulfate, 0.6mM of magnesium chloride hexahydrate, 1mM calcium 
chloride dehydrate, 30nmM of selenium, 1nM of manganese, 500nM of silicone, 
1nM of molybdenum, 5nM of vanadium, 1nM of nickel, 0.5nM of time,  1% (v/v 
final) of penicillin, 1% (v/v final) of streptomycin and 1%(v/v final) of fungazone. 
 
2.3.2 ELISA Buffers and Solutions 
IL-6 Coating Buffer 
To make 1000ml, 1.59g of 15mM Na2CO3 and 2.93g of 35mM of NaHCO3 was 




IL-6 Blocking Buffer 
To make 1000ml, 6.05g of Tris, 9g of Na2CO3 and 0.25g of NaN3 was first added to 
800ml of ddH2O. 3.5ml of 33% HCl was added to and pH to 7.4. 5g of BSA was 
added and the solution topped up to 1000ml.  
 
IL-6 TRF Wash Buffer (10x) 
To make 1000ml, 60.5g of Tris, 90g of NaCl and 2.5g of NaN3 was first added to 
800ml of ddH2O. 30ml of 33% HCl was added and pH to 7.8.Volume was topped up 
to make 1000ml. To make 1x TRF wash buffer, 1 part 10x TRF wash buffer was 
added to 9 parts ddH2O.  
 
IL-8 Assay Diluent 
To make 1000ml, 100ml of FCS was added to 900ml of 1x PBS. The solution was 
freshly prepared and used within 3 days of preparation and stored at 2-8°C.  
 
IL-8 Coating Buffer 
To make 1000ml, 7.13g of NaHCO3 and 1.59g of Na2CO3 was added to 1000ml of 
ddH2O and pH of solution was adjusted to 9.5. Solution was freshly prepared and 
used within 7 days of preparation, stored at 2-8°C. 
 
IL-8 Wash Buffer 
To make 1000ml, 100ml of 10x PBS and 500μl of Tween was added to 900ml of 
ddH2O. Solution was freshly prepared and used within 3 days of preparation, stored 
at 2-8°C.  
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Stop Solution (2N H2SO4) 
To make 100ml, 12.5ml of 18M H2SO4 was added to 100ml of H2O and stored at 
room temperature until required. 
 
2.3.3 Micro BCA Assay Working Reagent 
To obtain the working reagent, 50% (v/v final) of solution A, 48% (v/v final) of 
solution B and 2% (v/v final) of solution C from Pierce™ was added together. 
 
2.3.4 PCR Solutions 
PureLink DNase treatment 
For 1 sample, 80μl of DNase treatment was required. 8μl of 10X DNase I Reaction 
Buffer, 10μl of Resuspended DNase and 62μl of RNase Free Water was mixed 
together to obtain the final mixture.  
 
RT-PCR Master Mix 
For 1 sample, 2μl of 10x RT buffer, 4.4μl of 25mM MgCl2, 1μl of 40mM dNTP mix, 
1μl of Random Hexamers, 0.4μl of RNase Inhibitor and 0.5μl of MultiScribe 
Reverse Transcriptase was mixed together to obtain the final mixture.  
 
qPCR Master Mix 
To make a total of 15μl for 1 sample, 10μl of Sybr Green, 0.6μl of forward primer, 




2.3.5 Western Blot Buffers and Solutions 
2-(N-morpholino)ethanesulfonic acid Sodium Dodecyl Sulphate (MES SDS) 
Running buffer 
Stock MES SDS running buffer was obtained from Life Technologies Novex 
BOLT® (Melbourne, Vic, Aus) and used with all pre-cast gels electrophoresed using 
the Novex BOLT® system.  To prepare 1x MES SDS running buffer, 1 part of 20x 
MES SDS running buffer was diluted in 19 parts of ddH2O.  
 
TBS-T Wash Buffer 
To make 1000ml, 1.39g of Trizma Base, 6.06g of Trizma HCl and 8.77g of NaCl 
was first dissolved in 500ml of ddH2O using a magnetic stirrer. The pH of the 
solution was then adjusted to 7.6 using 12M HCl. Once pH has been reached, 0.5ml 




To make 1000ml, 0.5g of Coomassie Blue G 250 was added to 500ml of methanol, 
100ml of glacial acetic acid and 400ml of ddH2O in a fumehood. The solution was 
stored at room temperature until required. 
 
De-staining solution 
To make 1000ml of de-staining solution, 50ml of methanol and 70ml of glacial 
acetic acid was added to 880ml of ddH2O in a fumehood. The solution was stored at 
room temperature until required.  
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2.4 General Methods 
2.4.1 Ethics Approval 
The recruitment of preterm born infants at King Edwards Memorial Hospital, Perth, 
WA was approved by the Department of Health WA Human Research Ethics 
Committee (2014083EP).  Recruitment of healthy paediatric patients at St John of 
God Hospital, Perth, WA was approved by the St John of God Human Ethics 
Committee (#901). 
 
2.4.2 Standard Techniques 
Cell Count Using a Haemocytometer 
Total cell number in a solution was counted via the use of a haemocytometer. A 10μl 
aliquot of resuspended cell pellet was pipetted into a 0.65ml micro centrifuge tube. 
Ten microliters of Trypan blue was added to the tube and 10μl of the trypan blue 
dyed solution was placed onto the Nebauer haemocytometer to cell count under 10x 
magnification on the microscope. To calculate cell number, the following formula 
was used: 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑚𝑙 =
𝑇𝑜𝑡𝑎𝑙 𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠
4
× 2 × 10,000 
 
Cell Viability 
After the addition of Trypan Blue stain to the cell suspension, cell viability was 
calculated. Live cells do not take up Trypan Blue stain whilst dead cells absorbed the 
stain. To calculate cell viability, the following formula was used: 






2.4.3 Cell Sources 
Due to limited availability of primary cells, initial optimisation experiments and 
basic cell culture techniques were performed on immortalised cell lines or modified 
primary NECs. Immortalised cell lines were also used as calibration, standardisation 
and experimental control tools. NIH-3T3 cells were used as a feeder layer for 
primary NECs. Primary paediatric NECs were used subsequently for actual study 
results.  
 
16HBE14o- Cell line 
This immortalised human bronchial epithelial cell line was obtained from Dr Dieter 
Gruenert from the University of Vermont, USA (74). 
 
NIH-3T3 Cell line 
An immortalised murine fibroblast cell line was obtained from the American Type 
Culture Collection (ATCC) (Noble Park North, VIC, Australia). These were 
established from the embryonic tissue of a mouse (75).  
 
Nasal Epithelial Cells (NECs) 
The NECs used in this study were sourced from very prematurely born children and 
full-term born, healthy children. Nasal brushings of preterm born children were 
performed by a respiratory fellow at the 12 – 15 month lung function study follow-
up at Princess Margaret Hospital for Children, whilst under very light sedation. The 
full-term cohort consisted of children submitted into St John of God, Subiaco for 
elective surgery. Nasal brushing of full-term born children was performed under by 
the surgeon whilst the subject was under general anaesthetic.  
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2.4.4 Cell Culture 
2.4.4.1 16HBE14o- 
Thawing of 16HBE14o- 
Cryovials were retrieved from liquid nitrogen and thawed in a 37°C water bath. 
Contents were transferred to a tube containing 7ml of 16HBE140- media (refer to 
2.3.1) and centrifuged at 500 rcf for 7 minutes at 4°C. After centrifugation, 
supernatant was aspirated and cell pellet was resuspended in 16HBE14o- media. A 
cell count (refer to 2.4.2) was performed prior to seeding into sterile tissue culture 
flasks. Flasks were incubated at 37°C/5% CO2. 
 
Maintenance of 16HBE14o- 
Cultures were checked the day after seeding/thawing to check for any gross 
abnormalities. Checking of cells and subsequent media changes were then performed 




Cells were washed with 1x PBS before 1:4 T-EDTA (refer to 2.3.1) was added to the 
flask. The flask was then incubated at 37°C/5% CO2 for 1 minute and resulting cell 
suspension was collected into a tube and centrifuged at 500 rcf for 7 minutes at 4°C. 
After centrifugation, supernatant was aspirated and cells were resuspended in 
16HBE14o- media. A cell count was performed prior to seeding into sterile tissue 
culture flasks. Flasks were incubated at 37°C/5% CO2.  
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Cryopreservation of 16HBE14o- 
The volume of cell suspension required for 500,000 cells was calculated and 
aliquoted into cryovials. Cryovials were centrifuged at 1.2 rcf for 2 minutes in the 
microfuge. After centrifugation, supernatant was aspirated and cells were 
resuspended in 1ml of freezing media for each vial. Vials were placed into cool cells 
and balanced before placing into a -80°C freezer overnight. The next day, cryovials 
were placed into liquid nitrogen for long-term storage. 
 
2.4.4.2 NIH3T3 
Thawing of NIH-3T3 
Cryovials were retrieved from liquid nitrogen and thawed in a 37°C water bath. 
Contents were transferred to a tube containing 7ml of NIH-3T3 media (refer to 2.3.1) 
and centrifuged at 500 rcf for 7 minutes at 4°C. After centrifugation, supernatant was 
aspirated and cell pellet was resuspended in NIH-3T3 media. A cell count was 
performed prior to seeding into sterile tissue culture flasks. Flasks were incubated at 
37°C/5% CO2. 
 
Maintenance of NIH-3T3 
Cultures were checked the day after seeding/thawing to check for any abnormalities. 
Checking of cells and media changes were then done every second day. Cells were 
sub-cultured at 75-80% confluence and then maintained in 37°C/5% CO2. 
 
NIH-3T3 sub-culturing 
Cells were washed with 1x PBS before 1:2 T-EDTA (refer to 2.3.1) was added to the 
flask. The flask was then incubated at 37°C/5% CO2 for 1 minute and resulting cell 
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suspension was collected into a tube and centrifuged at 500 rcf for 7 minutes at 4°C. 
After centrifugation, supernatant was aspirated and cells were resuspended in NIH-
3T3 media. A cell count (refer to 2.4.2) was performed prior to seeding into sterile 
tissue culture flasks. Flasks were incubated at 37°C/5% CO2.  
 
Cryopreservation of NIH-3T3 
The volume of cell suspension required for 500,000 cells was calculated and 
aliquoted into cryovials. Cryovials were centrifuged at 1.2 rcf for 2 minutes in the 
microfuge. After centrifugation, supernatant was aspirated and cells were 
resuspended in 1ml of freezing media for each vial. Vials were placed into cool cells 
and balanced before placing into a -80°C freezer overnight. The next day, cryovials 
were placed into liquid nitrogen for long-term storage. 
 
Irradiation of NIH-3T3 
Cells were sub-cultured at 75-80% confluence. NIH-3T3 cells were split (refer to 
2.4.4.2) and prior to centrifugation were placed in a 50ml tube. After cells had been 
spun down and supernatant aspirated, the cell pellet was resuspended in 7ml of NIH-




2.4.4.3 NEC Cell Maintenance 
Processing of NECs 
A nasal brushing was used to isolate cells from the nasal turbinate. A cytology brush 
(BC 25105, Olympus, Australia) was inserted into the nasal passage and rotated 
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against the epithelial surface to collect for NECs. The brush was withdrawn and 
placed into a tube with 5 ml of collection media (refer to 2.3.1) and placed on ice. 
This step was repeated for a second brushing. Cells were taken back to the laboratory 
and processed. The tube was vortexed using MS1 Minishaker at high speed for 15 
seconds and the cytology brushes within were transferred to another tube prepared 
with collection media and vortexed again. Subsequently, the tube was centrifuged at 
500rcf for 7 minutes at 4°C. After centrifugation, supernatant was aspirated and the 
cell pellet was resuspended in NEC culture medium (refer to 2.3.1). A cell count and 
viability calculation was then performed (refer to 2.4.2). Macrophages were removed 
from the cell suspension using a CD68 antibody solution coated dish. The cell 
suspension was placed onto the pre-coated dish and incubated at 37°C/5% CO2 for 
20 minutes. Another cell count was performed post-macrophage removal prior to 
seeding cells into a fibronectin-coated flask and were incubated at 37°C/5% CO2. 
Macrophage RNA was also collected by adding 350μl of RLT buffer with 1% (v/v) 
β-Mercapto-ethanol was added to the CD-68 antibody coated petri dish. 
 
Thawing of NECs 
Prior to retrieving cells, a tube with 7ml of co-culture media was prepared along with 
pre-coated fibronectin flasks seeded with 125,000 irradiated NIH-3T3. Cells were 
retrieved from liquid nitrogen and then thawed in a 37°C water bath. Cryovial 
contents were transferred to the tube containing media and centrifuged at 500 rcf for 
7 minutes at 4°C. After centrifugation, supernatant was aspirated and the cell pellet 
was resuspended in co-culture media. A cell count was performed and the volume 
required for 125,000 cells was pipetted into fibronectin-coated flasks. Flasks were 
incubated at 37°C/5% CO2.  
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Maintenance of NECs 
Cultures were checked the day after seeding/thawing to check for any abnormalities. 
Checking of cells and media changes were then done every second day. Cells were 
sub-cultured at 65-85% confluence and then maintained in 37°C/5% CO2. 
 
Sub-culturing of NECs 
Primary nasal epithelial cells were expanded up to passage 3 for experimentation 
purposes. Cells were sub-cultured at about 65-85% confluence depending on the 
passage. A LONZA sub-culture reagent pack (LONZA™, Basel, Switzerland) was 
used for sub-culturing of NECs. Briefly, cells were firstly washed with tissue culture 
1x PBS before 1:100 T-EDTA was added for removal of fibroblasts. Cells were then 
washed with 1ml of HBSS solution before 1ml of T-EDTA was added for 
trypsinisation of the cells. The flask was placed in 37°C/5% CO2  for 5-7 minutes. 
After cells had detached off the flask, the trypsin process was stopped by adding 1 
ml of Trypsin Neutralising Solution (TNS). Flasks were then washed with culture 
media and the remaining cell suspension was placed into a sterile tube and 
centrifuged at 500 rcf for 7 minutes at 4°C. After centrifugation, supernatant was 
aspirated and the cell pellet was resuspended in NEC culture medium (refer to 2.3.1). 
A viability and cell count was performed and the volume required for 125,000 cells 
was pipetted into fibronectin-coated flasks (refer to 2.3.1). Flasks were incubated at 
37°C/5% CO2.  
 
Cryopreservation of NECs: 
The volume of cell suspension required for 500,000 cells was calculated and 
aliquoted into cryovials. Cryovials were centrifuged at 1.2 rcf for 2 minutes in the 
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microfuge. After centrifugation, supernatant was aspirated and cells were 
resuspended in 1ml of freezing media for each vial. Vials were placed into cool cells 
and balanced before placing into a -80°C freezer overnight. The next day, cryovials 
were placed into liquid nitrogen for long-term storage. 
 
2.5 MTS Assay 
To determine cell proliferation rates, a 3-[4,5-dimethylthiazol-2yl]-5-[3-
carboxymethoxyphenyl]-2-[4 sulfophenyl]-2H-tetrazolium inner salt (MTS) assay 
(Promega, Madison, WI) was used. This assay utilises a colorimetric method, 
measuring the bioreduction of MTS into an aqueous formazan product. Cells were 
seeded into a 96 well plate in triplicates at the following densities: 5,000, 10,000, 
15,000, 20,000, 25,000 and 30,000 cells with 100μl of BEGM media per well. The 
plate was left in a 37°C incubator overnight. Prior to commencement of the assay, 
cells were checked under a microscope to ensure that they had adhered to the bottom 
of the flask. Supernatant was aspirated and wells were washed with 100μl of PBS 
per well. PBS was aspirated and 100μl of clear RPMI-1640 media and 20μl of 
MTS/PMS solution was added to each well. Blank wells without cells were included 
as a negative control where clear RPMI-1640 media and MTS/PMS solution was 
also added. The plate was then incubated for a further 2 hours and then read at 
492nm absorbance on Multiskan FC plate reader using SkanIt for Multiskan FC 
2.5.1 or EnSpire® Multimode Plate Reader. 
 
2.6 Statistical Analysis 
Values are reported as either mean ± standard error of the mean (SEM) or mean ± 
standard deviation (SD) where appropriate. Unpaired t-test was used for paracmetric 
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data and Mann-Whitney statistical test was used for non-parametric data. All p 
values less than 0.05 were considered significant. GraphPad Prism 7.0 software 
package was used to perform statistical analysis. Image J software package was used 














Culturing Preterm Nasal Epithelial Cells 
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3.1 Introduction  
Preterm infants are born before 37 weeks of completed gestation. Their lungs are one 
of the last organs to develop in utero and are therefore immature at time of birth.  
Consequently, preterm born infants often require respiratory support soon after birth 
to help them breathe; usually in the form of invasive ventilation strategies 
accompanied with long periods of supplemental oxygen. These are lifesaving 
measures, but often injurious to the airway and lungs of the infants. Studies have 
shown that preterm infants have lung structural abnormalities as well as decreased 
lung function persisting into childhood and adolescence compared to their term 
counterparts (49, 50). Thus, there exists a need to characterise the airway of these 
children during infancy and early childhood in order to establish if there are any 
inherent or long term changes that occur as a result of premature birth.   
 
Currently, no studies have successfully characterised either the upper or lower 
airway epithelium of very preterm infants. Sampling of lower airway epithelial cells 
is invasive and therefore ethical considerations prevent access in high burden clinical 
cohorts like preterm infants. Interestingly, a number of studies have illustrated that 
nasal epithelial cells derived from the upper airway may be a potential surrogate for 
the lower airway in very young children (71-73). No gross morphological differences 
were observed between nasal and tracheal epithelial cells and both strongly 
expressed the epithelial lineage marker cytokeratin-19 (CK-19). Furthermore, the 
proportion of basal cells in nasal and tracheal cell cultures were similar. Both cell 
populations have been found to respond to proinflammatory stimuli with a similar 
magnitude of inflammatory cytokine and absolute mediator production (72) and both 
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nasal and tracheal cells were shown to fully differentiate in culture, displaying 
similar ciliary beat frequencies (73).  
 
With this in mind, this chapter aimed to establish and develop a pNEC model 
derived from children born prematurely. Specifically, this chapter tested the 
hypothesis that there would be morphological and functional differences in preterm 
NEC compared to full-term NEC. Cells were obtained from 13 preterm born and 9 
full-term born children and processed according to gold standard and modified 
culture establishment procedures. Successfully established cultures were then 
compared for morphological differences as well as their proliferative capacity.   
 
3.2 Methods  
Culturing of Airway Epithelial Cells 
Primary NECs were collected via brushing of the nasal turbinate. Overall, 13 preterm 
born infants and 9 healthy full-term born infants were recruited and sampled as 
described (refer to 2.4.3).  A subset of preterm samples (n=8) underwent matched 
gold standard processing (69, 76) as well as conditional reprogramming. A second 
set of NEC, derived from preterm (n=13) and term (n=9) children were then 
processed and conditionally reprogrammed to establish cultures. The conditional 
reprogramming methodology comprised of growing primary cells with irradiated 
fibroblasts as a feeder cell layer and ROCK inhibitor as described (refer to 2.4.4.3). 





During the first culture passage, pNECs at their first passage were seeded into a 96 
well tissue culture plate and maintained in BEGM SQ (refer to 2.3). Plates were then 
visualised using phase contrast microscopy and imaged via a live cell analysis 
system (IncuCyte®, ESSEN Biosciences). Overall morphology including size, and 
shape of pNEC from the full-term and preterm cohort was compared.  
 
Cell Proliferation  
Initial preliminary experiments were conducted to establish reference ranges for the 
MTS proliferation assay specifically for this study. Here, full-term NEC and preterm 
NEC were seeded into a 96 well tissue culture plate at 5,000, 10,000, 15,000, 20,000, 
25,000 and 30,000 cells per well in triplicate and left to adhere overnight. The MTS 
assay was then performed by initially removing growth media from each well, 
washing in PBS and finally adding 100μl of clear RPMI-1640 media and 20μl of 
MTS reagent per well (refer to 2.5). Plates were then incubated for 2 hours at 
37°C/5% CO2 before absorbance was read at 492nm.  
 
To compare cell proliferation rates, both full-term NECs (n=4) and preterm NECs 
(n=4) were seeded at 10,000 cells per well in a 96 well tissue culture plate and 
maintained in BEGM. The MTS assay was conducted at 24, 72 and 120 hours post 




Traditional vs Conditionally Reprogrammed Substudy  
Initial attempts to establish a culture model for preterm NECs utilised a routinely 
used gold standard culturing method and a matched conditionally reprogrammed 
approach. Nasal brushings were collected from 8 preterm subjects (5 males, average 
gestational age 29 ± 1.99 weeks). At time of brushing, infants ranged from 1.1-1.5 
years corrected age. Mean cell yields from nasal brushings were 9.5 ± 5.1 x 105 and 
the average viability was 28.3% (Table 3.1). All attempts at establishing primary cell 
cultures from any preterm infant via the traditional culturing methodology were 
unsuccessful. Conversely, a culture success rate of 87.5% was achieved utilising the 
conditional reprogramming approach. Conditionally reprogrammed cultures took on 
average 16 days (range: 12-21 days) to reach confluence from processing for 
passaging and continuing cell expansion. As preterm NEC were unable to be 
established under traditional culture methodology, only the conditionally 
reprogrammed method was used to generate full-term and preterm cell cultures for 
the downstream experiments of this study.  
 
Conditionally Reprogrammed Cohort 
Having proven that primary cell cultures could be established using conditional 
reprogramming, experiments were conducted to compare this approached between 
preterm and full-term born children. Here, NECs of 9 full-term subjects (5 males, 
2.09-2.6 years of age) and 13 preterm subjects (8 males, average gestational age 27.8 
± 2.6 weeks; 1.1-1.8 years corrected age) (Table 3.1) were collected and 
conditionally reprogrammed to establish cultures. An overall culture success rate of 
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over 95% was observed using this approach with success being independent of 
gender and gestational age of infant. When cohorts were stratified, cultures were 
successfully established from all full-term NECs achieving a 100% culture success 
rate. Mean cell yields were 17.1 ± 7.6 x 105 with an average viability of 34.5% 
(Table 3.1). Time taken to reach confluence averaged 11.9 ± 3.4 days (range; 8-19 
days; Table 3.1). Once established, culture maintenance periods were consistent over 
time with 7.5 ± 1.3 days (passage 1), 7.1 ± 0.8 days (passage 2) and 5.7 ± 1.4 days 
(passage 3) achieved (data not shown).   
 
For the total combined preterm cohort, the overall culture success rate was 92.3% 
with 12 of 13 cultures established via conditional reprogramming. Mean cell yield 
was 11.6 ± 8.4 x 105 with an average viability of 47% (Table 3.1). Confluence was 
reached with and average time of 15.7 ± 2.7 days (range; 12-21 days) (Table 3.1). 
Similar to their full-term counterparts, cultures maintenance periods for preterm 
NECs were 7.7 ± 0.8 days (passage 1), 6.4 ± 2.1 days (passage 2) and 6.4 ± 2.5 days 
(passage 3; data not shown). When cohorts were compared, cell yields from full-term 
NECs were 1.5 fold greater than preterm NECs, however, this was not considered 
significant (p>0.05) (Table 3.1). Interestingly, preterm NECs took a significantly 
longer time period to reach confluence from processing than preterm NECs (15.7 ± 
2.7 vs 11.9 ± 3.4 days; p<0.05).  However, within each cohort, this time period was 
independent of gender, gestational age and cell yield. Finally, there was not observed 




Having successfully established a methodology to grow preterm NECs, resultant 
cellular morphologies were then investigated and compared. Nasal epithelial cells 
from all established cultures typically exhibited a cobblestone morphology 
archetypal of epithelial cells (Figure 3.1). Full-term NECs were all of consistent size 
and shape with little variability between participants when established cultures were 
compared. In addition, no difference in morphology, cell size and shape was 
observed over the culture duration in this study (passage 3; data not shown). A 
similar cobblestone morphology was observed in preterm NECs. Here, no difference 
in cell shape and size was observed between cohort participants or over extended 
culture with repeated passage (Figure 3.1).  
 
Cell Proliferation Rates 
Having determined no differences in established cultures at the morphological level, 
cell division turnover was investigated to ascertain if there were difference between 
full-term NECs and preterm NECs. Initial preliminary experiments validated the 
MTS assay with results showing colour intensity correlating will cell number in both 
full-term (R2= 0.9994) and preterm NECs (R2= 0.9814; Figure 3.2A). When 
optimised experiments were performed, full-term NECs displayed a liner 
proliferation rate for the duration of the assay (122h; R2=0.88; Figure 3.2B). 
Interestingly, preterm NECs displayed a less linear proliferation rate when compared 
to their full-term counterparts (R2=0.69) with a longer lag time (~72hrs) observed 




Table 3.1 Cellular yield, viability and time taken to reach confluence of cells derived from nasal sampling obtained from full-term and 
preterm children. CR - Conditional reprogramming. ND - Not determined. DNE - did not establish. 
Study ID Gender Age* (years) Cell yield Viability (%) Time taken to reach confluence (days) 
     CR Traditional 
PRETERM 1 F 1.2 4.95 x 105 28 19 DNE 
PRETERM 2 F 1.3 6.90 x 105 54 14 DNE 
PRETERM 3 M 1.1 1.19 x 106 82 16 DNE 
PRETERM 4 M 1.2 7.25 x 105 19 12 DNE 
PRETERM 5 F 1.5 3.15 x 105 40 DNE DNE 
PRETERM 6 M 1.3 1.92 x 106 71 21 DNE 
PRETERM 7 M 1.2 1.18 x 106 62 15 DNE 
PRETERM 8 M 1.2 1.07 x 106 36 15 DNE 
PRETERM 9 F 1.7 3.10 x 105 8 17  
PRETERM 10 F 1.8 2.55 x 105 20 18  
PRETERM 11 M 1.4 1.28 x 106 64 15  
PRETERM 12 M 1.8 1.42 x 106 32 13  
PRETERM 13 M 1,1 3.35 x 106 56 13  
       
FULL TERM 1 F 2.1 1.38 x 106 ND 15  
FULL TERM 2 M 2.2 2.60 x 106 ND 13  
FULL TERM 3 M 2.2 1.55 x 106 36 19  
 FULL TERM 4 M 2.1 1.47 x 106 49 8  
 FULL TERM 5 M 2.8 1.83 x 106 36 11  
FULL TERM 6 M 2.5 6.20 x 105 33 12  
FULL TERM 7 F 2.6 1.45 x 106 27 11  
FULL TERM 8 F 2.6 3.20 x 106 23 9  
FULL TERM 9 F 2.1 1.31 x 106 37 9  
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FULL-TERM        PRETERM 
Figure 3.1. Cell morphology of full-term and preterm NECs obtained from nasal 
brushings. No morphological variations were seen between full-term and preterm 
NECs where a typical epithelial morphology was observed. Left hand panels: Primary 
NECs obtained from 2 full-term born children. Right hand panels: Primary NECs 
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 55 
Figure 3.2. Proliferation rates of full-term and preterm NECs over time assessed 
using a colorimetric MTS assay. (A) Primary NECs were seeded in triplicates at 5000 
– 30000 cells per well. After 2 hours, an MTS assay was conducted.  (B) Primary NECs 
were seeded in triplicates at 10,000 cells per well in a 96 well tissue culture plate. At 24, 
72 and 120 hours, an MTS assay was conducted. Proliferation rates of full-term and 
preterm NECs.  
  






















T e r m
P r e t e r m
A





















T e r m
P r e t e r m
 56 
3.4 Discussion 
This chapter has shown the successful establishment of pNEC from both full-term and 
preterm infants utilising a conditional reprogramming methodology. Specifically, it has 
shown for the first time the ability to culture cells from preterm infants that was 
otherwise unsuccessful using traditional gold standard methods. Primary NEC cultures 
successfully established, exhibiting a cobblestone morphology, were serially passaged 
(here passaged up to 3 times), with no differences in overall morphology observed or 
over successive passage. Interestingly, analysis of the growth kinetics of these cells 
revealed a potentially lower proliferative capacity of preterm NECs, when compared to 
full-term NECs suggesting some functional differences in these cells.  
 
Preterm born infants have altered lung structure and lower lung function that persists 
into early adolescence and mechanisms leading to these abnormalities are still unknown 
(50, 77). Other consequences also include higher risk of and more adverse reactions to 
viral infections than full-term counterparts. To facilitate more research into the 
biological mechanisms that underlie these pathologies, a cellular model of the preterm 
epithelium is necessary. To date, only one other study has attempted culturing nasal 
airway cells from a limited sample size from this particular cohort (78). Via trialing and 
comparing traditional gold standard and conditional reprogramming methodologies, 
pNECs from a preterm cohort has been successfully established.  
 
Using current gold standard methodologies for processing and culturing bronchial 
epithelial cells, a very low culture success rate was observed with preterm pNEC. 
Considering this traditional methodology consistently cultures healthy and disease 
bronchial epithelial cells (69, 70, 78, 79) these results likely reveal an underlying 
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fragility of their airway epithelium. This appears further validated considering the 
traditional methodology has also been used successful to establish pNECs from 
newborn neonates (48hrs old) (71). Although a gold standard approach, the lack of 
success here, lead to the development of an alternative cell processing and culture 
establishment methodology (71).  
 
For the first time, we report a novel methodology that resultantly facilitates the 
successful establishment of preterm NECs using conditional reprogramming. This 
approach, has been shown to facilitate extended culturing without alteration of the 
cellular characteristics (79). In this study, although one sample did not successfully 
establish, a culture success rate of >90% was achieved using conditional 
reprogramming for preterm NECs. This is significantly greater than the 0% success rate 
using traditional processing and culturing means. Furthermore, these cells were 
successfully maintained up to passage 3. This is one of the first studies to report the 
successful establishment of pNECs from infants, preterm children and adults (78).  
 
Having established a methodology to established primary cell cultures from preterm 
children, the next step involved their preliminary characterisation. Similar to cell yields 
and viability attained in this experiment, cell yields from nasal brushings of other 
studies have ranged from 13 x 103 to 3.3 x 106 cells, with an average viability range of 
40-50% (71, 80, 81). One of the interesting observations made in this chapter, was the 
higher (1.5 fold) cell yields derived from full-term pNEC. One explanation for this 
difference was that all full-term born children were fully anaesthetised under a general 
anaesthetic at time of sampling, allowing for easier collection of cells thus resulting in a 
higher cell yield. Nasal sampling of preterm born children were collected whilst under 
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very light sedation. As a result, children were able to feel the sampling apparatus, 
possibly contributing to a lower cell yield.  
 
Excitingly, via conditional reprogramming a culture success rate of >90% was 
observed. Successful establishment of cultures was independent of cell yield, cell 
viability, gender of child, gestational age and birth weight. Interestingly, time taken to 
reach confluence was significantly longer in the preterm cohort (15.2 ± 0.8 days) than 
term cohort (11.9 ± 1.15 days) (p<0.05). Time taken to reach confluence for pNECs 
from both cohorts are comparable to previous findings (69), however longer when 
compared to another study that established cells from an adult cohort (81). A longer 
time was taken to reach confluence in pNECs from full-term and preterm children 
compared to an adult cohort possibly because a lower cell obtained from sampling The 
observation of a longer time taken for cell establishment in the preterm cohort could be 
attributed to the immaturity of these cells or the fact that the preterm children were 
significantly younger that their full-term counterparts at time of sampling. 
 
Cellular morphology was then assessed following successful establishment of pNECs. 
Overall cellular morphology from preterm NECs were similar to full-term NECs where 
both cohorts maintained a cobblestone morphology typical of epithelial cells (69, 70, 
82). Morphology observed in a co-culture model was similar to cells cultured using the 
traditional method, indicating conditional reprogramming appears to not permanently 
alter the cells. In both cohorts, cells from different patients all exhibited identical 
cellular morphology and were comparable to previous descriptions made of these cells 
(71, 72). Furthermore, the uniformity of the cobblestone appearance implied a pure 
population of epithelial cells free from contamination of other cell types. This 
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morphology was observed over continuous passage, further confirming cells were of 
epithelial lineage and had not been altered.  
 
As no differences were found in the cellular morphology of pNECs from full-term and 
preterm born children, cell proliferation rates were subsequently assessed. Full-term 
NECs appeared to proliferate in a linear manner over the five days. Interestingly, a 
slower growth rate was observed in preterm NECs. Potentially, the cell lag phase may 
have been captured during this experiment consequently reflecting the time period that 
preterm NECs have taken to settle in an artificial environment prior to starting 
proliferation. This may be indicative of an in vitro culturing artifact or that preterm 
NECs may in fact have a longer population doubling time than their full-term 
counterparts. A suggestive slower cell turnover rate adds additional rationale to the ideal 
of airway epithelial fragility in these airways, which could be a result of respiratory 
support and oxygen-induced injuries sustained in early life.  Future experiments could 
expose cells to various O2 concentrations and via the use of flow cytometry, assess for 
cell damage. 
 
In summary, this chapter has demonstrated successful establishment of pNEC from full-
term and preterm children via conditional reprogramming. Cell yields and establishment 
times were comparable to similar studies using other cohort subjects (neonates and 
adults) using traditional culturing methodologies (71, 80, 81). Cellular morphology did 
not differ between the two cohorts, with both exhibiting a cobblestone morphology over 
continuous passage. The lack of change in observation reconfirms no alteration via 
effects of passaging. Interestingly, we did observe that pNEC from the preterm cohort 
had a slower rate of proliferation than their full-term counterparts that may be 
contributing to their overall fragility. To further reconfirm this chapter’s hypothesis, 
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gene expression of epithelial lineage markers were corroborated with corresponding 















Chapter 4:  
 




The airway epithelium functions as the initial protective interface between the internal 
milieu of the lung tissue and the external environment within the human respiratory 
tract. Intrinsic differences in airway epithelium can drive respiratory disease. For 
example, the airway epithelium of asthmatic children show differences in CK-5 and 
CK-19 gene expression and basal IL-6 and EGF cytokine production (69). Such 
inherent differences suggest an altered asthmatic airway epithelium that would 
resultantly impact on its barrier integrity function when injured or exposed to agents 
such as viral infection (69, 83). Due to being born prematurely, before in utero lung 
development is completed, it is suggested that the airway epithelium of these infants are 
more immature than their full-term born counterparts (5, 7). In addition, post-natal 
management of infants after preterm birth can expose infants to stimuli such as invasive 
ventilation strategies and supplemental oxygen. Whether early life therapies can alter 
the characteristics and function of airway epithelium is also unknown and how long any 
possible changes arising from premature birth persist into early childhood. 
 
Cytokeratins are keratin proteins that are typically found in the cytoplasm of epithelial 
cells and their expression patterns can indicate specific epithelial cell types (84). 
Cytokeratin 19 is an intermediate protein expressed in both simple and stratified 
epithelia in the lung (85, 86) and is typically used to confirm epithelial lineage of a cell. 
Cytokeratin-5 is a basal progenitor cell marker, largely expressed in basal cell types 
typically with CK-14 (87, 88) and often indicates the level of cell maturity. Mostly a 
marker of mesenchymal cells or cells undergoing epithelial-mesenchymal transition 




Having successfully established and optimised a methodology for NEC culture from 
full-term and preterm children in the previous chapter, this chapter aimed to characterise 
NECs to test the hypothesis that there would be lineage and biochemical differences 
between the preterm and healthy cohorts. Initially, established cultures were assessed 
for archetypal lineage markers at gene level. Expression levels were then assessed over 
extended passage. An exclusion lineage gene, vimentin, was also included to further 
verify lineage. Epithelial lineage was then corroborated at protein level using 
immunocytochemistry and western blot analysis. From this data, a preliminary basal 
cytokine profile was created. Results were further stratified into BPD and non-BPD 
phenotypes within the preterm cohort as BPD can lead to development arrest, altering 
the structure of the lung (90). This is due to lung immaturity and continuous insults 
from supplemental oxygen subsequently affecting airway tissue and epithelial cells (90). 
Various pro-inflammatory cytokines are also associated with BPD during the neonatal 
period (36). This has potential consequences on the characterisation of epithelial cells 
from preterm infants. 
 
4.2 Methods 
Real time PCR was utilised for analyses of CK-5, CK-19 and vimentin gene expression. 
Approximately 1 million cells were collected for RNA extraction using RLT buffer 
(refer to 2.3). RNA samples from full-term and preterm born NECs at passage 1 and 3 
were extracted (as previously described by Kicic et al. 2006, Sutanto et al. 2011) 
performed using a PureLink RNA Mini Kit (Life Technologies, Mulgrave, VIC, 
Australia). Quality and quantity of RNA was assessed using the Nanodrop 2000 
program. To convert RNA to cDNA, the MultiScribe Reverse Transcription (RT) kit 
(ThermoFisher Scientific, Waltham, MA, USA) was utilised according to the 
manufacturer’s instructions. Briefly, 9.3μl of Master Mix, 200ng of RNA from each 
 64 
sample and remaining amount of RNase Free Water was placed into the designated 
micro centrifuge tube. Samples were then vortexed and centrifuged for ~15 seconds 
before being placed into the Bio-Rad thermal cycler and run at 25°C for 10 minutes, 
48°C for 1 hour, 95°C for 5 minutes and 4°C for infinite hold. Gene expression of 
samples were quantified using SYBR® Green qPCR. Master Mix for the housekeeping 
gene and gene of interest were prepared and qPCR was then performed under the 
following conditions: 2 minutes at 50°C, 10 minutes at 95°C, 40 reps of 15 seconds at 
95°C, 1 minute at 60°C. The primers used are described in Table 4.1. RNA obtained 
from the cell lines ME-180 and NIH-3T3 acted as positive controls for CK-5/CK-19 and 
vimentin analyses respectively. Cyclophillin A (PPIA) was utilised as a housekeeping 
gene, which was identified to be uniformly expressed between healthy and disease 
airway epithelial cells and thus most suitable normaliser in studies involving these 
cells(91). Results generated were analysed using the 2-∆∆CT method and reported as 
mean ± standard error. 
 
Fluorescent Immunocytochemistry 
Fluorescent immunocytochemistry was used qualitatively to determine protein 
expression of CK-5 and CK-19. Approximately 50,000 cells at relevant passages were 
cytospun onto glass microscopic slides, fixed in NBF (refer to 2.3) and dried. Slides 
were rehydrated in 1x PBS (refer to 2.3) and incubated with 200μl of quenching 
solution (0.5% w/v final Sudan Black) for 20 minutes. Fifty microliters of 36μl/ml 
proteinase K was added to the slide which was then incubated for 30 minutes at 37°C 
for antigen retrieval. Slides were then stained for CK-5 (1:100 dilution) and CK-19 
(1:50 dilution) primary antibody, (as previously described by Kicic et al. 2006), Alexa 
Fluor 488 (1:500), was used for secondary antibody staining. 4’,6-Diamidino-2-
phenylindole, dihydrchloride (DAPI; 1:50,000) was used for cell nucleus staining. 
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Visualisation of specific antibody staining was performed using a fluorescent 
microscope (Leica Microsystems Pty Ltd, Wetzlar, Germany). Subsequent analyses 
were completed using the image processing analysis program ImageJ (92) to quantify 
pixel intensities of randomly selected image sections. 
 
Bicinchoninic Acid (BCA) Assay 
The Pierce BCA assay (Thermo Fisher Scientific, USA) was used to determine total 
protein concentration from cells obtained from protein extraction (refer to 2.3) 
according to manufacturer’s instructions. Briefly, protein samples were thawed on ice 
while standards were prepared and pipetted into a 96 well plate. A working stock of 
1:10 and 1:4 was prepared by adding 900μl of PBS to 100μl BCA stock standard and 
1050μl of PBS to 350μl BCA stock standard respectively. Serial dilutions were 
performed from the 1:10 working standard to obtain 12.5, 25, 50, 75, 100, 125, 150, 
175, 200μg/ml standards. Serial dilutions were also performed from the 1:4 working 
standards to obtain 300, 400 and 500μg/ml standard. Protein samples were diluted 1:10 
and 1:25. To perform the assay, 40uL of both standards and samples were pipetted onto 
the microplate. BCA reagent percentages (of total required volume) are as follows: 50% 
(v/v final) of Reagent A, 48% (v/v final) of Reagent B and 2% (v/v final) of Reagent C. 
Then 200μl of the BCA reagent was pipetted onto samples and incubated at 37°C for 1 
hour. The plate was read on the SkanIt for Multiskan FC 2.5.1. at 595nm. 
 
Western Blot 
Western Blots were used to validate fluorescent immunocytochemistry assessment of 
both CK-5 and CK-19. Approximately, 1 x 106 cells were lysed in 450μl of CEB (refer 
to 2.3) and 50μl of proteinase inhibitor.  After total protein was determined by the BCA 
assay, a total of 10μg of protein and pre-stained ladders were electrophoresed onto a 
12% (w/v) 1.0mm Bis-Tris + polyacrylamide (BOLT) gel at 200V for 30 minutes. 
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Protein bands were then transferred onto a polyvinylidene difluoride membrane using 
the iBlot system (Invitrogen, Melbourne, VIC, Australia) at 200V for 7 minutes. 
Membranes were then blocked in Li-Cor Blocking Buffer for 1 hour prior to an 
overnight incubation with either CK-5 (1:2000) or CK-19 (1:1000000) primary 
antibody. Membranes were then washed 3 times in 1x TBS-T wash buffer (refer to 
2.3.5) before 2 hour incubation with IRDye 680RD/800RD Goat anti-Rabbit (1:10000) 
secondary antibody. Prior to membrane scanning, membranes were washed a final 3 
times using TBS-T wash buffer.  Beta-actin was utilised as the housekeeping protein. 
Membranes and protein gel were scanned at 700 and 800 nm and protein expression 
visualised using a Li-Cor Odyssey Infrared Scanner (LI-COR Biosciences, Lincoln, NE, 
USA). Subsequent analyses was completed using the image processing analysis 
program ImageJ (92) to quantify band intensity.  
 
Supernatant Collection: 
Relevant cellular supernatant was collected and analysed using an Enzyme Linked 
Immunoabsorbent Assay (ELISA). Prior to splitting cells, media from flasks were 
transferred into a tube and centrifuged at 500 rcf for 7 minutes at 4°C. The supernatant 
was aliquoted out into micro centrifuge tubes, avoiding agitation of the cell pellet; and 
stored at -80°C until required. 
 
IL-8 Production 
IL-8 production levels over culture passage was determined via commercial ELISA 
(Becton Dickinson, Biosciences, San Diego, CA) according to manufacturer’s 
instructions. Briefly, serial dilutions of 200pg/ml standard was prepared from the stock 
standard to obtain 100pg/ml, 50pg/ml, 25pg/ml, 12.5pg/ml, 6.3pg/ml and 3.1pg/ml 
standards. Costar EIA Half-Area 96 well plates (Thermo Fisher Scientific, Scoresby, 
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Vic, Aus) were coated overnight with 50μl of 1:250 IL-8 primary antibody diluted in 
coating buffer, sealed and kept at 4°C. The next day, wells were aspirated and washed 3 
times with 150μl of wash buffer (refer to 2.3.2). All subsequent incubations were done 
at room temperature on a shaker. Wells were then blocked with 100μl of assay diluent 
for 1 hour. After incubation, wells were washed 3 times. Fifty microliters of the blank, 
standards and sample dilutions pipetted into designated wells, the plate was sealed and 
then incubated for 2 hours. After incubation, wells were washed 5 times and 50μl of 
prepared working detection antibody solution was pipetted into wells, plate was sealed 
and incubated for 1 hour. After incubation, wells were washed 7 times and 50μl of 
3,3’5,5’-Tetramethylbenzidine (TMB) substrate solution was added to wells and 
incubated in the dark for 30 minutes. After incubation, 25μl of acid-based stop solution 
(refer to 2.3.2) was added to the wells and absorbance was read on the SkanIt for 
Multiskan FC 2.5.1 at 450nm wavelength. Assessment of IL-8 cytokine production was 
performed on unstimulated samples from full-term NECs and preterm NECs and 
performed as previously described (69, 70). Results were standardised to pg/ml/106 cells 
and reported as mean ± standard error. 
 
IL-6 Production 
Baseline IL-6 cytokine production levels over culture passage was determined by a 
dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA) (PerkinElmer, 
Waltham, MA, USA).  Briefly, standard concentrations: 30000pg/ml, 10000pg/ml, 
3000pg/ml, 1000pg/ml 300pg/ml, 100pg/ml, 30pg/ml, 10pg/ml, 3pg/ml, 1pg/ml and 
0.3pg/ml were prepared by performing serial dilutions in DELFIA Assay Buffer (Perkin 
Elmer, Waltham, MA, USA). NUNC Maxisorp 96 well plates (Thermo Fisher 
Scientific, Scoresby, Victoria) were coated overnight with 50μl of 1:250 IL-6 primary 
antibody diluted in coating buffer (refer to 2.3.2), sealed and kept at 4°C. All 
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subsequent incubations were done at room temperature on a shaker. The next day, 
coating buffer was removed and 300μl of blocking buffer (refer to 2.3.2) was added to 
the wells. The plate was incubated for 1 hour. After incubation, block buffer was 
removed and wells were washed 4 times by submerging plate in wash buffer (refer to 
2.3.2). Fifty microliters of the blank, standards and sample dilutions pipetted into 
designated wells, the plate was sealed and then incubated for 1 hour. After incubation, 
wells were washed 5 times as previously described. Fifty microliters of biotinylated 
secondary antibody diluted 1:500 was added to each well and incubated for 1 hour and 
washed 5 times. Fifty microliters of Streptavidin-labelled Europium (Perkin Elmer, 
Waltham, MA, USA) was added to each well and incubated for 30 minutes followed by 
8 washes. Fifty microliters of Enhancement Solution was added to each well and 
incubated for 5 minutes. After incubation, the plate was read on a CLARIOStar with 
wavelength parameters of 320nm excitation and 615nm emission for Europium time-
resolved fluorescence. Assessment of IL-6 cytokine production was performed on 
unstimulated samples from full-term and pre-term NEC as routinely performed in this 




Baseline EGF cytokine production levels over culture passage were determined via 
commercial ELISA (elisakit.com, Scoresby, Vic, Aus) according to manufacturer’s 
instructions. Assessment of EGF cytokine production was performed on unstimulated 
samples from full-term and pre-term NEC as previously described (69, 70). Results 
were standardised to pg/ml/106 cells and reported as mean ± standard error. Briefly, 
standards of 500pg/ml, 250pg/ml, 125pg/ml, 62.5pg/ml, 31.25pg/ml, 15.6pg/ml and 
7.8pg/ml concentrations were prepared. All incubations were performed at room 
 69 
temperature on a shaker. Fifty microliters of 1b assay diluent was added to each well of 
the pre-coated microplate. 50μl of the blank, standards and samples was added, the plate 
was sealed and incubated for 2 hours. After incubation, wells were washed 4 times with 
250μl of wash buffer per well. One hundred microliters of biotinylated secondary 
antibody was added to each well and incubated for 2 hours. Wells were then washed 4 
times and 100μl of 1:500 streptavidin-horseradish peroxidase was added to each well 
and incubated for 45 minutes. Wells were then washed 5 times and 100μl of TMB 
substrate solution was added to each well and incubated for 15 minutes in the dark. The 
reaction was stopped with 50μl of acid-based stop solution (refer to 2.3.2) and 
absorbance was read on the SkanIt for Multiskan FC 2.5.1. at 450nm wavelength.  
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 Forward Primer Reverse Primer 
CK-5 5’TGGAGATCGCCACTTACCG3’ 5’CCAGAGGAAACACTGCTTGTG3’ 
CK-19 5’ATAAAAGCCAGGTGAGG3’ 5’GCTGTAGGAAGTCATGGCGA3’ 
Vimentin 5’GAGGAGATGCGGGAGCTG3’ 5’ATGATGTCCTCGGCGAGGTT3’ 
PPIA 5’CCTTGGGCCGCGTCTCCTTT3’ 5’CACCACCCTGACACATAAACCCTGG3’ 
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4.3 Results 
Real Time PCR 
Gene expression of full-term and preterm NECs was assessed over passage to 
validate the expression of CK-19, CK-5 and vimentin.  
 
CK-19 Gene Expression 
Expectantly, all cultures were found to express CK-19. Interestingly, at passage 1, 
preterm NECs had a higher expression of CK-19 gene than full-term NECs (1.95 ± 
0.5 vs 0.78 ± 0.17; p<0.05; Figure 4.1). There were no significant differences 
between full-term and preterm NECs at P3 (0.75 ± 0.39 vs 1.07 ± 0.34). Over 
continuous passage, no difference was observed in CK-19 expression in full-term 
NECs (P1 vs P3: 0.79 ± 0.17 vs 0.75 ± 0.39; p>0.05; Figure 4.1.1). Similarly, a 
slight decrease in CK-19 expression was observed in preterm NECs (P1 vs P3: 1.95 
± 0.5 vs 1.07 ± 0.34; p>0.05; Figure 4.1.2). When the preterm cohort was stratified 
according to BPD diagnosis, CK-19 expression were not significantly different over 
passage 1 and 3 (1.19 ± 1.68 for BPD & 0.64 ± 0.32 for non-BPD; p>0.05; Figure 
4.1.2).  
 
CK-5 Gene Expression 
Similar to CK-19, all cultures were found to express CK-5. No significant changes 
were observed between full-term and preterm NECs at each passage, passage 1: 
(0.45 ± 0.16 vs 0.82 ± 0.23; p>0.05), passage 3 (0.39 ± 0.14 vs 0.75 ± 0.21; p>0.05; 
Figure 4.2). Over continuous passage CK-5 expression decreased slightly within 
full-term NECs although this was considered not to be significant (P1 vs P3: 0.45 ± 
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0.16 vs 0.39 ± 0.14; p>0.05; Figure 4.2.1). Within preterm NECs, CK-5 expression 
levels also slightly decreased over passage but was not considered significant (P1 vs 
P3: 0.82 ± 0.23 vs 0.75 ± 0.21; p>0.05; Figure 4.2.2). When stratified according to 
BPD development, CK-5 expression were not significantly different over passage 
(3.12 ± 6.1 for BPD & 1.33 ± 0.47 for non-BPD; p>0.05; Figure 4.2.2).  
 
Vimentin Gene Expression 
Compared to both CK-19 and CK-5, vimentin expression was markedly lower.  No 
significant changes were observed between full-term and preterm NECs at each 
passage; passage 1: (3.03 ± 0.8 x 10-3 vs 6.34 ± 1.67 x 10-3; p>0.05), passage 3 (3.95 
± 1.35 x 10-3 vs 13.2 ± 4.8 x 10-3; p>0.05; Figure 4.3). Over continuous passage, 
vimentin expression in full-term NECs was similar (P1 vs P3: 3.03 ± 0.8 x 10
-3 vs 4 
± 1.4 x 10-3; p>0.05; Figure 4.3.1). A slightly larger increase was observed in 
preterm NECs, (6.34 ± 1.67 x 10-3 vs 13.2 ± 4.8 x 10-3; p>0.05; Figure 4.3.2). When 
stratified according to BPD development, no significant difference was observed 
between the BPD vs non-BPD phenotype over passage (4.91 ± 7.73 for BPD & 2.01 



















Figure 4.1. Cytokeratin 19 gene expression by full-term and preterm NECs. 
RNA samples from full-term and preterm NECs were collected and analysed using 
qPCR. Data was presented as CK-19 expression relative to the housekeeping gene 
PPIA. Open dots are BPD diagnosed preterm children. Cytokeratin 19 was expressed 
by both cohorts and expression was maintained over continuous passage. 
Interestingly, CK-19 gene expression was significantly higher in preterm than term 
cohort at P1 (p<0.05). There were no significant differences at P3 between the two 





















































Figure 4.1.1. Cytokeratin 19 gene expression from full-term controls over 
passages. Data was presented as CK-19 expression relative to PPIA, the 
housekeeping gene. (A) Cytokeratin 19 expression did not differ significantly from 
passage 1 to passage 3 in full-term NECs. (B) Trend lines depicting CK-19 gene 
expression over passage. Overall, most cultures maintained similar CK-19 




































































Figure 4.1.2. Cytokeratin 19 gene expression in preterm NECs over continuous 
passage. Data was presented as CK-19 expression relative to PPIA, the 
housekeeping gene. Open dots are BPD diagnosed preterm children. (A) Cytokeratin 
19 expression did not differ significantly from passage 1 to passage 3 in preterm 
NECs. (B) Trend lines depicting CK-19 gene expression over passage. Some 
individual cultures expressed high CK-19 at P1 but decreased expression at P3. (C) 
Trend exhibited for CK-19 expression over continuous passage from non-BPD 
diagnosed preterm NECs. (D) Trend exhibited for CK-19 expression over continuous 
passage from non-BPD diagnosed preterm NECs. Fold change values are presented 










































































































































Figure 4.2. Cytokeratin 5 gene expression by full-term and preterm NECs. RNA samples 
from full-term and preterm NECs were collected and analysed using qPCR. Data was 
presented as CK-5 expression relative to PPIA, the housekeeping gene. Open dots are BPD 
diagnosed preterm NECs. Cytokeratin 5 was expressed by both cohorts and expression was 
maintained over continuous passage. There were no significant differences between full-term 


























































Figure 4.2.1. Cytokeratin 5 gene expression from full-term controls over 
passages. Data was presented as CK-5 expression relative to PPIA, the 
housekeeping gene. (A) Cytokeratin 5 expression did not differ significantly from 
passage 1 to passage 3 in full-term NEC. (B) Trend lines depicting CK-5 gene 






























































Figure 4.2.2. Cytokeratin 5 gene expression in preterm NECs over continuous 
passage. Data was presented as CK-5 expression relative to PPIA, the housekeeping 
gene. Open dots are BPD diagnosed preterm children. (A) Cytokeratin 5 expression 
did not differ significantly from passage 1 to passage 3 in preterm NECs. (B) Trend 
lines depicting CK-5 gene expression over passage. (C) Trend exhibited for CK-5 
expression over continuous passage from non-BPD diagnosed preterm NECs. (D) 
Trend exhibited for CK-5 expression over continuous passage from non-BPD 
diagnosed preterm NECs. Fold change values are presented as mean ± standard 








































































































































Figure 4.3. Vimentin gene expression by full-term and preterm NECs. RNA 
samples from full-term and preterm NECs were collected and analysed using qPCR. 
Data was presented as vimentin expression relative to PPIA, the housekeeping gene. 
Open dots are BPD diagnosed preterm children. Vimentin was expressed by both 
cohorts and expression was maintained over continuous passage. There were no 
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Figure 4.3.1. Vimentin gene expression from full-term controls over passages. 
Data was presented as vimentin expression relative to PPIA, the housekeeping gene. 
(A) Vimentin expression did not differ significantly from passage 1 to passage 3 in 
full-term NECs. (B) Trend lines depicting Vimentin gene expression over passage.  
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Figure 4.3.2. Vimentin gene expression in preterm NEC over continuous 
passage. Data was presented as vimentin expression relative to PPIA, the 
housekeeping gene. Open dots are BPD diagnosed preterm children. (A) Vimentin 
expression did not differ significantly from passage 1 to passage 3 in preterm NECs. 
(B) Trend lines depicting vimentin gene expression over passage. (C) Trend 
exhibited for vimentin expression over continuous passage from non-BPD diagnosed 
preterm NECs. (D) Trend exhibited for vimentin expression over continuous passage 
from non-BPD diagnosed preterm NECs. Fold change values are presented as mean 
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Protein analysis  
CK-19 Staining 
All cultures stained positive for CK-19 indicating epithelial lineage (Figure 4.4). 
Though a range of staining intensity was observed with individual slides, a much 
stronger staining intensity was observed with slides from full-term NECs than 
preterm NECs (Figure 4.4A/B)  When assessed via western blot, full-term NECs 
displayed a wide variance of protein expression for CK-19 which was not observed 
for preterm NECs (Figure 4.6A/B) . Though not significantly different, a higher 
expression of CK-19 protein was observed in full-term NECs than preterm NECs 
(0.91 ± 0.34 vs 0.58 ± 0.14; p>0.05; Figure 4.6.1). 
 
CK-5 Staining 
Immunofluorescent analysis revealed that all cultures also stained positive for CK-5, 
with a similar intensity of staining between patients (Figure 4.5). A greater intensity 
of staining was observed with CK-5 staining in preterm NEC slides compared to 
their full-term counterparts (Figure 4.5A/B). Protein expression was then 
corroborated via western blot. As a result of the dimerisation of CK-5 [55 kDA] with 
CK-14 [52 kDA], two bands were observed on the membrane (Figure 4.7A/B). 
Expression in full-term NECs was consistent between all individuals (Figure 4.5A). 
Interestingly, the preterm cohort displayed a much larger variance in CK5 staining 
(Figure 4.5B). Though not significantly different, an overall higher expression of CK 
5 was observed in the preterm NECs when compared to full-term NECs (37.55 ± 








Figure 4.4. Cytokeratin-19 (CK-19) protein staining via fluorescent 
immunocytochemistry in full-term and preterm NECs. (A) Staining intensity 











Figure 4.5. Cytokeratin-5 (CK-5) protein staining via fluorescent 
immunocytochemistry in full-term and preterm NECs. (A) Staining intensity 







































Figure 4.6. Cytokeratin-19 protein expression analysed via Western Blot. 
Protein samples from full-term NECs and preterm NECs were collected and analysed 
using Western Blot. Data was presented as CK-19 relative to the housekeeping 
protein, β-Actin (A) L: Full-term NECs R: Preterm NECs. B) No significant 
differences were observed between the two cohorts though CK-19 was more highly 



























































Figure 4.7. Cytokeratin-5 protein expression analysed via Western Blot. Protein 
samples from full-term NECs and preterm NECs were collected and analysed using 
Western Blot. Data was presented as CK-5 relative to the housekeeping protein, β-
Actin (A) L: Full-term NECs R: Preterm NECs. B) No significant differences were 
observed between the two cohorts though CK-5 was more highly expressed in 
preterm than full-term NECs (37.55 ± 9.86 vs 83.74 ± 29.1). 
 
















































No significant difference was observed in IL-8 cytokine production between full-
term and preterm NECs at passage 1 (15153 ± 3730 vs 13252 ± 3972; p>0.05; Figure 
4.8). However, IL-8 production was significantly higher in preterm children at 
passage 3 (15413 ± 5960 vs 31587 ± 3933; p<0.05; Figure 4.8). Interleukin-8 
production in full-term NECs were similar over passage (15153 ± 3730 vs 15413 ± 
5960; Figure 4.8.1). In preterm NECs, IL-8 production levels were significantly 
increased over passage (P1 vs P3, 13252 ± 3972 vs 31587 ± 3933; p<0.05; Figure 
4.8.2). When stratified, no significant difference was observed between BPD and 
non-BPD phenotypes over passage (4.39 ± 2.57for BPD & 1.73 ± 0.71 for non-BPD; 
p>0.05; Figure 4.8.2).  
 
IL-6 ELISA 
Interluekin-6 cytokine production between the two cohorts was not significantly 
different passage 1: (105.1 ± 62.05 vs 106.2 ± 60.66; p>0.05), passage 3 (361.5 ± 
144.3 vs 267.8 ± 103.5; p>0.05; Figure 4.9). Over continuous passage, an increase in 
IL-6 production within full-term NECs was observed (105.1 ± 62.05 vs 361.5 ± 
144.3; p>0.05; Figure 4.9.1). Similarly in preterm NECs, an increase in IL-6 
production was observed (106.2 ± 60.66 vs 267.8 ± 103.5; p>0.05; Figure 4.9.2). 
When stratified according to the development of BPD, no significant difference was 
seen between BPD vs non-BPD phenotype over passage (16.29 ± 32.47 for BPD & 






Production of EGF cytokine did not differ significantly between full-term and 
preterm NECs, passage 1: (10308 ± 3505 vs 10697 ± 4446; p>0.05), passage 3: 
(16475 ± 2942 vs 39401 ± 15034; p>0.05; Figure 4.10).Epidermal growth factor 
cytokine production in full-term NECs increased over continuous passages (10308 ± 
3505 vs 16475 ± 2942; p>0.05; Figure 4.10.1) There were similar observations for 
preterm NECs over continuous passage (10697 ± 4446 vs 39401 ± 15034; p>0.05; 
Figure 4.10.2). When stratified according to the development of BPD, no significant 
difference was seen between BPD vs non-BPD phenotype over passage (17.75 ± 



















Figure 4.8. Cytokine Interleukin-8 (IL-8) production levels between full-term 
and preterm NECs. Cell supernatant was collected at every passage at each split for 
analysis of IL-8 production via ELISA. Data collected was standardised to 1 x 106 
cells. Open circles are BPD diagnosed preterm children. IL-8 was produced by both 
cohorts at passage 1 and passage 3. There were no significant differences at P1 but 
full-term and preterm NECs were significantly different at P3. A significant 
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Figure 4.8.1. Cytokine Interleukin-8 (IL-8) production levels from full-term 
controls over passages. Data collected was standardised to 1 x 106 cells. Values are 
reported as mean ± standard error. (A) Similar levels of IL-8 was produced at 
passage 1 and passage 3 (P1 vs P3, 15153 ± 11190 vs 15413 ± 14598) by full-term 
NECs. (B) There were no significant differences observed over P1 and P3 for full-
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Figure 4.8.2. Cytokine Interleukin-8 (IL-8) production levels from preterm 
NECs. Data collected was standardised to 1 x 106 cells. Open circles are BPD 
diagnosed preterm children. (A) A significant difference for preterm NECs was 
observed over continuous passage (P1 vs P3, 13252 ± 11915 vs 31587 ± 11125) 
(p=0.004). (B) A significant difference was observed over P1 and P3 for preterm 
NECs. A 3.39 ± 2.41 fold change was observed over passage. (C) Trend exhibited 
for IL-8 production over continuous passage from non-BPD diagnosed preterm 
NECs. All BPD diagnosed preterm children show a general increase in IL-8 
production over continuous passage. (D) Trend exhibited for IL-8 production over 
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Figure 4.9. Cytokine Interleukin-6 (IL-6) production levels between full-term 
and preterm NECs. Cell supernatant was collected at every passage at each split for 
analysis of IL-6 production via ELISA. Data collected was standardised to 1 x 106 
cells. Open dots are BPD diagnosed preterm children. (A) IL-6 was produced by 
both cohorts at passage 1 and passage 3. Full-term and preterm NECs at passage 1 
produced similar levels of IL-6 (105.1 ± 186.1 vs 106.2 ± 182).  There were no 








































































Figure 4.9.1. Cytokine Interleukin-6 (IL-6) production levels from full-term 
controls over passages. Data collected was standardised to 1 x 106 cells. . (A) IL-6 
production levels for full-term NECs increased (3.43 fold change), but failed to reach 
































































































Figure 4.9.2. Cytokine Interleukin-6 (IL-6) production levels from preterm 
NECs. Data collected was standardised to 1 x 106 cells. Open dots are BPD 
diagnosed preterm children. (A) A 2.5-fold change was observed over passage for 
IL-6 production by preterm NECs (P1 vs P3, 106.2 ± 182 vs 267.8 ± 310.5). (B) 
There were no significant differences observed over P1 and P3 for preterm NECs. A 
12.48 ± 23.6 fold increase was observed over continuous passage. (C) Trend 
exhibited for IL-6 production over continuous passage from non-BPD diagnosed 
preterm NECs. (D) Trend exhibited for IL-6 production over continuous passage 
from non-BPD diagnosed preterm NECs. All non-BPD diagnosed preterm NECs 
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Figure 4.10. Cytokine Epidermal Growth Factor (EGF) production levels 
between full-term and preterm NECs. Cell supernatant was collected at every 
passage at each split for analysis of EGF production via ELISA. Data collected was 
standardised to 1 x 106 cells. Open dots are BPD diagnosed preterm children. (A)  
EGF was produced by both cohorts at passage 1 and passage 3. There were no 
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Figure 4.10.1. Cytokine Epidermal Growth Factor (EGF) production from term 
controls over passages. Data collected was standardised to 1 x 106 cells. (A) A 1.5 
fold change was observed over passage for EGF production by full-term NECs (P1 
vs P3, 10308 ± 3503 vs 16475 ± 2942). (B) There were no significant differences 
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Figure 4.10.2. Cytokine Epidermal Growth Factor (EGF) production levels from 
preterm NECs. Data collected was standardised to 1 x 106 cells. Open dots are BPD 
diagnosed preterm children. (A) An approximate 3.5 fold change (exact: 3.68) was 
observed over passage for EGF production by preterm NECs (P1 vs P3, 10697 ± 4446 
vs 39401 ± 15034). (B) There were no significant differences observed over P1 and P3 
for preterm NECs. A 14.49 ± 19.96 fold increase was observed over continuous 
passage. (C) Trend exhibited for EGF production over continuous passage from non-
BPD diagnosed preterm NECs. (D) Trend exhibited for BPD production over 
continuous passage from non-BPD diagnosed preterm NECs. All non-BPD diagnosed 
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This chapter compared lineage expression and cytokine production of primary NEC 
from preterm born children to those of their full-term counterparts. At passage 1, 
preterm NECs had a significantly higher expression of CK-19 compared to full-term 
NECs. Gene expression of CK-5 and vimentin did not differ significantly between the 
two cohorts and over continuous passage. Gene expression was corroborated at protein 
level and opposite to the gene expression findings, namely a higher CK-19 protein 
expression was observed in full-term NECs. Immunocytochemistry also revealed higher 
expression of CK-19 in full-term NECs. Cytokine production at basal culture state 
observed IL-8 production by preterm cultures significantly increase over passage and 
this resulted in IL-8 levels significantly higher than the full-term cohort. In contrast, 
production of IL-6 and EGF cytokine did not significantly differ between the cohorts or 
over continuous passage. There were no significant differences within the preterm 
cohort when stratified by BPD. Overall, this chapter has demonstrated that at the 
baseline culture state, preterm NECs do not greatly differ from full-term NECs in 
epithelial lineage markers, pro-inflammatory and proliferative cytokine production  
 
Expression of different cytokeratins by epithelial cells largely depends on the 
differentiation status of the epithelial cell (93). Cytokeratin-19 is found in simple 
columnar epithelium with ability to differentiate and also in stratified epithelia (84, 94), 
whilst CK-5 is expressed by basal state cells in squamous stratified epithelia (85, 93, 
95). Changes in cytokeratin expression can be a marker of underlying disease 
pathology. For example Kicic et al. 2006 highlighted changes in CK-5 expression in 
asthmatic airway epithelium that was indicative of a more immature epithelium (69). 
Accompanying these differences to non-asthmatic epithelium in cytokeratin expression 
are altered expression of tight junction proteins and functional discrepancies in 
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differentiation (69, 96, 97). Interestingly, in the present study, CK-19 gene expression 
was higher in preterm NECs than full-term NECs. Furthermore, when stratified, CK-19 
and CK-5 gene expression was independent of gestational age, birth weight or time on 
respiratory support. Vimentin, a marker of cells undergoing or having underwent 
epithelial-mesenchymal transition (EMT), is typically expressed by mesenchymal cells. 
Since, minimal levels of vimentin expression was measured compared to CK-19 and 
CK-5 in this chapter confirms that the established cell population consisted of epithelial 
cells. Very low levels of expression maintained over passage also indicates that lineage 
was maintained over extended passage in vitro.  
 
Gene expression was followed by corroboration at the protein level. Results revealed 
differential CK-19 expression at the protein level in preterm NECs. Preterm NECs had 
higher gene expression of CK-19 that was not reflected at protein level, signifying 
potential post-transcriptional or post-translational factors (98, 99). Alternatively, 
mechanisms in vivo may have suppressed the maturation of preterm children’s epithelial 
cells and once placed in an in vitro environment, free from various other cell-
interactions and signaling, preterm NECs are subsequently allowed to mature. Lung 
morphogenesis and homeostasis is known to be regulated by Wnt/β-catenin transduction 
pathway (100). In pulmonary diseases, Wnt signaling is involved in lung inflammation, 
lung fibrosis and carcinomas (101). The WNT signaling pathway mediates 
differentiation of epithelial tissue (102) where suppression of the pathway allows 
undifferentiated progenitor cells to begin differentiation and when signaling is active, 
differentiation is suppressed (103, 104).  An active Wnt signaling pathway could be 
present in preterm infants and affect airway epithelium maturation in vivo and as such 
may be an important area of future work. After analysis of protein, baseline levels pro-
inflammatory cytokines were assessed. 
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This study found preterm NECs had higher production of IL-8 compared to full-term 
NECs at passage 3 and also over continuous passage. The finding that IL-8 production 
by term NEC remained similar over continuous passage corroborates another study that 
showed functionality by healthy cells under this culture technique remaining unchanged 
up to passage 7 (67). Furthermore, a study by Teig et al. 2012 reported levels of IL-8 
are elevated in airways of preterm born adolescents compared to full-term born peers 
(105). Taking into the account the data reported here and elsewhere, it could be 
suggested that preterm NECs may have a lower threshold for stress, in this case long-
term cell culturing. The increase in IL-8 over continuous passage was observed for the 
BPD cohort, which marries with data of increased IL-8 levels in bronchoalveolar lavage 
(BAL) fluid from preterm children that were diagnosed with BPD (106). Another study 
by Huang et al. 2000, found that preterm infants born at from 24 to 32 weeks gestational 
age had higher levels of IL-8 in their BAL fluid compared to later preterm and term 
infants (107). Preterm infants from this cohort ranged from 24 to 31 weeks gestational 
age. Overall, the IL-8 data presented here provides further evidence for an increased 
inflammatory baseline in the preterm airway.  
 
There were no differences observed in the levels of IL-6 and EGF between cohorts. 
Interleukin-6 and EGF are signaling molecules typically involved in early phases of 
inflammation (108). The NECs of this study were not stimulated by pathogens or other 
injury prior to collection of supernatant and children of both cohorts were not 
symptomatic at time of nasal brushing. This may be a contributing reason as to why no 
differences were observed. It is known that the immune responses of preterm infants are 
not immature and they are capable of eliciting release of acute pro-inflammatory 
cytokines in response to infections (109). Interleukin-6 is a pro-inflammatory cytokine 
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and present in conditions such as neonatal sepsis (110, 111), necrotizing enterocolitis 
(112) but is also present in infants with bronchopulmonary dysplasia (113, 114). 
Increased levels of IL-6 present in infants with BPD appears to suggest that the airways 
of these infants are in a permanent state of inflammation. Interleukin-6 has been used as 
a marker for infants developing BPD (115, 116) and infants with BPD are known to 
have elevated levels of IL-6 (117). But interestingly, a study by Rocha et al. 2012 found 
lower levels of IL-6 in small-for-gestational-age infants with severe/moderate BPD than 
their non-BPD counterparts (113). Contrasting findings may be attributed to different 
criterion for BPD diagnosis and age of recruited infants in individual studies (118). The 
data presented in this chapter found the BPD group produced higher levels of IL-6 at 
passage 1 but the inverse was observed at passage 3. No differences in IL-6 production 
between the full-term and preterm cohort suggests that at basal conditions free from 
infections and stimulation from pathogens, baseline production is similar between full-
term and preterm born children.  
 
Epidermal growth factor is involved in cellular proliferation, differentiation (119) and 
wound healing within epithelia (120). The production of EGF usually sparse in the 
airways, however its expression has been associated with asthma (121) and pulmonary 
fibrosis (122).  In the setting of a developing lung, EGF is thought to be involved in the 
regulation of fetal lung development and repair of the epithelium post injury (123). 
There are limited studies about EGF in the context of preterm airway diseases but EGF 
has been indicated to exert effects on the functional maturation of epithelial cells and 
morphogenesis of the lung (123). Apart from disruption at the distal airway epithelium, 
when lungs of BPD diagnosed preterm infants were compared to non-BPD preterm 
infants, pattern of EGF expression were similar (123). The data presented in this chapter 
is comparable to earlier results where similar levels of EGF were seen between BPD 
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and non-BPD phenotypes though a higher mean was observed in the non-BPD 
phenotype at passage 3. When full-term NEC EGF production levels were compared to 
preterm NEC EGF production, similar levels were observed for full-term NECs at P1, 
P3 and preterm NECs P1. A high mean of EGF at P3 by preterm NECs could be 
indicative of innate stress and inflammation. The culture medium for NECs contained 
exogenous EGF but this was not the major contributor to the observed baseline levels.  
In summary and contrary to the hypothesis, cytokeratins and cytokines were largely 
similar between full-term and preterm cohorts, with the major exceptions that the CK-
19 gene was more highly expressed in preterm NECs. These cells also produced more 
IL-8 after extended culturing. Many factors could attribute to this but the discrepancies 
between gene and protein levels could suggest some post-transcriptional modifications 
as well as possible suppression of epithelial cell maturation. To determine whether these 
baseline inconsistencies are accompanied by functional differences, full-term NECs and 














Using Air Liquid Interface Culture as a 
Model for the Preterm Airway  
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5.1 Introduction 
The airway epithelium is a biologically complex structure consisting of a continuous 
sheet of airway epithelial cells covering the airway conduit. A healthy respiratory 
epithelium is multilayered and consists of a pseudostratified columnar layer. This is 
comprised of basal, goblet, mucous and ciliated cells each having importance including 
playing progenitor and structural roles, mucous production and mucous transport 
assisting in clearing of pathogens respectively (124). Once thought to be just a physical 
barrier from inhaled pathogens, the respiratory epithelium has also been recognised in 
eliciting immune responses to foreign bodies like viruses and allergens (124) as well as 
airway inflammation (125). The airway epithelium functions to protect the body from 
the external environment eliciting rapid repair when injured to reinstate its barrier 
integrity.  
 
Barrier function of the airway epithelium is critical in acting as a barricade between 
pathogens and the internal milieu. Barrier integrity of the airway epithelium is typically 
measured using qualitative methods including confocal microscopy but is more 
appropriately measured via  transepithelial permeability as previously detailed (126). In 
asthma, where the airway epithelium plays an important role in disease pathogenesis 
and progression, the airway epithelial barrier function has been found to differ to non-
asthmatic airway and it thought to contribute to allergy sensitisation (127). Cellular 
migration and differentiation are hallmark processes of repair and defects in these are 
typical of some airway diseases such as asthma (128, 129). 
 
In the previous chapter, characterisation of preterm NECs in comparison to full-term 
NECs found similarities in basal cytokine production, gene and protein expression. The 
next step was to establish whether any baseline differences in airway functionality exist 
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between these cohorts. The two key functions of the airway epithelium that can drive 
respiratory disease if defective are transepithelial permeability and wound repair. Since 
significant structural and immune pathologies can be observed in the preterm lung, it is 
of interest to look at preterm airway epithelium function to verify whether there are 
differences to a full-term model. Therefore the aims of chapter 5 were to investigate the 
integrity and reparative capacity of the preterm and full-term airway. Primary nasal 
epithelial cells from preterm born cohort were hypothesised to have a weaker barrier 




Establishment of air-liquid interface (ALI) cultures 
Primary nasal epithelial cells obtained from preterm born and full-term born infants 
were grown in an ALI model. In preparation, 6.5mm Transwell-Clear 0.4μm pore size 
inserts were coated with type I, rat tail collagen (60μg/ml) (refer to 2.3) prior to seeding 
of cells. The volume of cell suspension for 150,000 cells for each well were aliquoted 
into micro centrifuge tube and then centrifuged for 2 minutes at 1.2 rcf. Prior to seeding 
cells on the insert membrane, the apical well was washed twice with 1x PBS to remove 
residual collagen. Cells were then resuspended in 200μl of ALI media containing 1μl/ml 
of ROCK inhibitor (refer to 2.3) per insert and pipetted into the apical well. The 
basolateral well was filled with 1ml of ALI media. Plates incubated at 37°C/5% CO2.  
 
Maintenance of ALI cultures: 
Apical and basolateral media was changed every day with ALI media (refer to 2.3.1) 
containing 1μl/ml of ROCK inhibitor. Upon reaching confluence, cells were air-lifted, 
where media from the apical well was removed. Residual ROCK inhibitor was removed 
 106 
via washing with 1x PBS. This was considered day 0 post airlift. Every second day, 
basolateral media was replaced with 1ml of fresh media. Maximal differentiation of 
cells were ensured by growing cultures to 28 days post airlift. Presence of beating cilia 
was considered a hallmark of epithelial cell differentiation.  
 
Transepithelial Electrical Resistance (TEER) Measurements: 
At day 7, 14, 21 and 28 post-airlifting, triplicate TEER measurements were taken for 
each insert as routine assessment of cell differentiation. An epithelial voltmeter was 
prepared by wiping down with ethanol and placing the probes in ethanol, air dried and 
then placed in DMEM media before being turned on. ALI media was aspirated from the 
basolateral well and both apical and basolateral wells were replaced with DMEM 
media. The baseline reading was recorded and subtracted from the readings taken. The 
resistance obtained from a cell-free culture insert was taken from the mean resistance 
for each insert and then corrected for the surface area of the insert to yield the final 
TEER measurement with the value expressed in Ω.cm2.  
 
Transepithelial Permeability Assay 
At 28 days post airlifting, cells were utilised for a transepithelial permeability assay as 
previously described by Hubatsch et al. 2007 (126). Two hundred microliters of 
fluorescently-labelled inert molecules (FITC) dissolved in HEPES-HBSS buffer (refer 
to 2.3) was added to the apical well and HEPES-HBSS wash buffer was added to the 
basolateral well. The culture plate was incubated on an orbital shaker, speed setting ~3, 
at 37°C/5% CO2 for a time period of 6 hours. Incubation on an orbital shaker was 
performed to minimise stagnation of the unstirred layers and simulate a dynamic 
environment similar to the in vivo setting. A 15 minute wash step, washing the inserts 
with HEPES-HBSS was conducted prior to the start of the experiment and at the end. At 
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0h, 0.5h, 1h, 2h, 3h, 4h, 5h and 6h time points, 500μl of HEPES-HBSS from the 
basolateral compartment was removed and replaced with the same volume of fresh 
HEPES-HBSS. Fifty microliters of the sample from each time point was transferred to a 
96 well black plate and read using EnSpire at 492nm excitation wavelength and 520nm 
emission wavelength. Inserts were fixed in Carnoy’s solution (refer to 2.3) for 24 hours 
and then transferred to 100% absolute ethanol for H&E staining. Inserts were kept at 
4°C until required. 
 
Wound Repair 
Wound repair experiments were performed using a high-throughput scratch wounding 
method coupled with time-lapse imaging. Briefly, primary nasal epithelial cells were 
seeded onto FN-coated ImageLock 96-well plates (Essen Bioscience, Ann Arbor, MI, 
USA) and grown to confluence in BEGM SQ (refer to 2.3). Cultures were then 
incubated in EGF-free BEGM SQ (refer to 2.3) 24 hours prior to wounding. Cell 
monolayers were wounded using the 96-well Essen Bioscience CellPlayer® 
WoundMaker® (Abacus ALS, Meadowbrook, QLD, Australia), creating consistent 
wounds in all wells of 700-800 μm width (130). Wounded culture monolayers were 
washed twice in BEBM to remove cellular debris. Cultures were incubated in EGF-free 
BEGM SQ media at 37°C in an atmosphere of 5% CO2 / 95% air until full wound repair 
was achieved. Time-lapse images were captured and analysed every 30 minutes with the 
IncuCyte® ZOOM (Essen Bioscience) machine in order to determine the rate of repair. 
Wound recovery was calculated manually using ImageJ by automatic measurement of 
the wound surface area in the monolayer at each time interval. Calculated values were 







A typical cobblestone morphology was observed for both preterm and term NEC during 
the initial submerged stage of ALI culture when visualised using light microscopy. At 
~20 days post airlift, beating cilia was observed for all 4 preterm cultures and 2 term 
cultures via 40x magnification. Staining of sectioned ALI cultures with H&E dye 
revealed both full-term and preterm NECs had the ability to differentiate into 
multilayered, ciliated epithelium (Figure 5.1). A multicellular layer consisting of 
approximately 2 to 3 layers was formed by both cohorts. There was expression of cilia 
in both cohorts. Visual assessment saw a less unified extent of ciliation across the 
surface of preterm ALI cultures when compared to full-term. A total of 18 attempts 
were made to establish ALI cultures from paediatric NECs (Table 5.1). However, only 4 
preterm and 4 full-term ALI cultures were functional at 28 days post airlifting. Culture 
establishment success/failure rates were the same between full-term and preterm NECs 
(p>0.05). Cultures that did not survive till day 28 typically displayed from day 7~21 a 
stressed morphology including cell enlargement, loss of confluence and perfusion of 
basal media into the apical space that overall, typically indicative that the ALI culture 
was not successful. A significantly higher success rate was observed with ALI cultures 
set up at the passage 1 split compared to cultures that were set up at the passage 2 split 
(p<0.05). 
 
Transepithelial Permeability Assay 
On the 28th day, a transepithelial permeability assay was conducted on culture inserts to 
assess cell permeability. Results generated showed that preterm NECs had a 
significantly lower pApp coefficient for both 4 and 20 FITC-dextran particle sizes in 
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comparison to full-term NECs (Figure 5.2; p<0.05). Specifically, preterm NECs 
demonstrated a significantly lower transepithelial permeability to 4kDa FITC-dextran 
(59.7 x 10-4 ± 15.45 cm/sec) than full-term (324 x 10-4 ± 112.9 cm/sec; Figure 5.2; 
p<0.05). This was also observed for the 20 kDA FITC-dextran, where preterm had 
significantly lower transepithelial permeability (43.26 x 10-4 ± 20.09 cm/sec) than full-
term (415.9 x 10-4 ± 82.31 cm/sec; Figure 5.2: p<0.05). A low transepithelial electrical 
resistance (RT) was corroborated with high permeability coefficient (pApp) in full-term 
NECs (Figure 5.3), whilst in preterm NECs, low RT was corroborated with low pApp 
(Figure 5.3).  
 
Wound Repair 
Wound closure of four preterm NECs was recorded and individually compared to 
grouped full-term control data (Figure 5.4). At 24 hours, wound closure was 85% full-
term NECs whereas preterm NECs varied in closure (range; 13.75 – 57.75%). Wound 
closure for preterm NECs were lower than their full-term counterparts at 24 hours (34.1 
± 9.04 vs 85 ± 0; p<0.05; Figure 5.4). Full-term NECs were able to fully repair wounds 
over the 72 hour time course. In contrast, preterm NECs displayed more varied wound 
repair capacities (range; 28.25 – 94.25%). Interestingly, one preterm culture was able to 
fully repair similar to the full-term control (Figure 5.4A). However, three other preterm 
NEC cultures exhibited defective wound closure ranging from less than 30% up to 80% 
(Figure 5.4B-D). As such, wound repair at 72 hours by preterm NECs was significantly 
lower than repair by full-term NECs (62.2% ± 13.7 vs 100% ± 0; p<0.05; Figure 5.4). 
Interestingly, the preterm culture that repaired at a similar rate to full-term NECs 
(Figure 5.4A) had the lowest amount of respiratory support (837 hours) and did not 
have BPD, compared to the rest of the preterm cultures (837-2066 hours). There was no 
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association between wound closure rates and infant’s GA, birth weight, BPD diagnosis, 
gender and respiratory support. 
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Table 5.1. Establishment of air-liquid interface (ALI) cultures 
 Generated Succeeded Failed 
Preterm 9 4 5 
Full-term 9 4 5 
Total 18 8 10 
Amount of air-liquid interface cultures from full-term born and preterm born children 
that successfully established and failed.   
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Figure 5.1. Haemotoxylin & Eosin staining of ALI cultures from full-term and preterm NECs at 100x magnification. (A) Multicellular layer 
























Figure 5.2. Comparison of transepithelial permeability for pNECs derived from 
preterm and full-term born children, 4 kDa and 20 kDa FITC-dextran. At 28 days 
post air-lifting, ALI cultures were assessed for epithelial permeability utilising a 
permeability assay. 4 and 20 kDa FITC-dextran particle sizes were used. (A) 
Transepithelial permeability for full-term NECs showed significant difference in 
permeability for 4kDa FITC-dextran particles and 20kDa FITC-dextran particles. 4 
kDA: (324 ± 112.9 vs 59.75 ± 15.45), 20 kDA: (415.9 ± 82.31 vs 43.26 ± 20.09). 
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Figure 5.3. Permeability coefficient and RT of full-term and preterm NECs. At 28 
days post air-lifting, ALI cultures were assessed for epithelial permeability utilising a 
permeability assay. 4 and 20 kDa FITC-dextran particle sizes were used. Transepithelial 
electrical resistance measurements were also taken to corroborate permeability assay 
results. (A) Transepithelial permeability for full-term NECs showed significant 
difference in permeability for 4kDa FITC-dextran particles and 20kDa FITC-dextran 
particles. 4 kDA: (324 ± 112.9 vs 59.75 ± 15.45), 20 kDA: (415.9 ± 82.31 vs 43.26 ± 
20.09). Lower RT measurements in full-term NECs corroborate with an increased 
transepithelial permeability. Higher RT measurements in preterm NECs corroborate 
results of reduced transepithelial permeability.  p<0.05 (*) was considered significant.
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Figure 5.4. Percentage of wound closure over time for preterm NECs compared to full-term NECs. Wound repair over 72 hours from four 
individual preterm NECs compared to mean values from four full-term controls. Blue – Full-term NEC, Red – Preterm NECs. C, D – Preterm infants 
exposed to chorioamniotis. 









































































































                                            
Figure 5.5. Percentage of wound closure at 24 and 72 hours for preterm NECs compared to full-term NECs. Wound repair at 24 and 72 hours 
from four individual preterm NECs compared to mean values from four full-term controls.* p<0.05, ** p<0.01. 
 





























Airway epithelial cells line the airway epithelium and by acting as a barrier, protect 
the underlying tissue from inhaled material and possible pathogens. This chapter has 
demonstrated that air-liquid interface cultures of multiple cell layers with cilia can be 
successfully established from primary preterm NEC.  Interestingly, transepithelial 
permeability results found that preterm NEC were significantly less permeable in 
comparison to full-term NECs. A low RT measurement was corroborated with high 
apparent permeability coefficient in full-term NECs and the opposite was observed 
for preterm NECs. Also observed were significantly lower wound repair by preterm 
NECs compared to their full-term counterparts at 24 and 72 hours post wounding.  
 
Though widely utilised, a submerged monolayer cell culture model does not truly 
reflect the complex structure of the airway epithelium in vivo. The multi-layered 
nature of the airway epithelium can be more accurately represented in an air-liquid 
interface (ALI) culture model. Establishment and maintenance of ALI cultures can 
be challenging and here 45% of cultures survived till 28 days post airlift for both 
phenotypes. Retraction of cells and cell layers lifting off were the main processes 
observed during unsuccessful culture.  
 
Air-liquid interface culture failure could be attributed to a few factors. Firstly, cells 
that were of a very fragile nature would not grow in an ALI model. After assessment, 
no correlations were found between ALI culture successes and failures according to 
gender, GA, birth weight, time on respiratory support or BPD diagnosis. As no 
significant correlations were found between culture failures and clinical data of 
preterm children, with success rates identical in the full-term cohort, ALI failures 
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may be attributed to technical reasons. Cryopreservation and primary cells of later 
passage both of which may have reduced the capability of cells to adequately 
proliferate and differentiate under ALI cultures. The process of cryopreservation can 
compromise cell tissue integrity and cell viability post thaw (131, 132). Future 
experiments could establish ALI cultures at an earlier passage or ex vivo to ensure a 
culture success. Similar establishment rates seen in the preterm cohort could be 
attributed to the establishment of ALI cultures at an earlier passage split.  
 
In an ALI model, NECs have the ability to differentiate into ciliated and goblet cells 
with mucous production, representative of an in vivo  model (133). Preterm NECs 
exhibited a similar capacity to full-term NECs in forming a multilayered, 
differentiated epithelium. Cilia formation is a hallmark of epithelial cell 
differentiation and though both phenotypes developed cilia, unquantified 
observations suggested ciliation was more wide spread on full-term ALI cultures 
than preterm. Since sustained insults that disrupt tight junctions can affect barrier 
function and differentiation of the airway epithelium (134), the ability of preterm 
NECs to differentiate in a similar manner to full-term NECs suggests  that 
immaturity of NECs may not be sustained into early life.  
 
With pNECs available, culturing them in an ALI model allows for investigation into 
barrier integrity of the airway epithelium in vitro. Airway epithelial integrity can be 
disrupted by respiratory viruses and such which increase paracellular permeability 
leading to a ‘leaky’ epithelium. Using full-term NECs as a baseline control, the 
barrier integrity of preterm NECs was found to be less leaky than full-term NECs. 
Contrary to the hypothesis, the preterm airway epithelium was found to be less 
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permeable than one of full-term children. The airway epithelium will exhibit some 
degree of paracellular permeability as it is important and required for healthy 
function, specifically for the selective transport of solutes (135). An abnormally 
lower transepithelial permeability observed in preterm NECs suggest that early life 
treatments that were injurious to the preterm infant’s airway may have upregulated 
paracellular tight junction proteins leading to increased barrier integrity which results 
in a reduction of transepithelial permeability. Future studies could assess the 
expression of tight junction proteins; like claudins, occludens and ZO-1 of the 
airway epithelium. From observations of low transepithelial permeability in preterm 
NECs, it could also suggest higher amounts of fibrotic tissue present and future 
studies could use animal models to test whether early life treatments lead to its 
formation. Fluorescent immunohistochemistry can then be used to identify markers 
associated with scar tissue and healthy skeletal muscle tissue (136). Though a 
significant difference was observed in transepithelial permeability of full-term and 
preterm children, assessment of barrier integrity from larger numbers are still 
required.  
 
Antenatal steroids are known change the structure of the lung and could possibly 
attribute to lower transepithelial permeability seen in preterm NECs. However, 
whether steroids alter tight junctions regulating paracellular permeability of the cell 
is unknown. Mothers from all preterm born infants from this cohort received 
antenatal steroids. Additionally, culturing methods requires the presence of 
hydrocortisone in ALI media. Steroid administration has been proven to accelerate 
maturation of the foetal lung, specifically acceleration of alveolar wall thinning and 
microvascular maturation (137). As a result of the maturation process, lung structure 
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is ultimately changed. A previous investigation showed in an sheep model, steroid 
administration resulted in a decrease of alveolar wall thickness together with 
reduction in total lung weight, which could be attributed to thinning of the alveolar 
septa (138). Interestingly, in this model reduction of total lung weight was only 
observed in female foetuses. The effects of steroid administration have only been 
looked at in the setting of altered lung structure and thus future experiments may 
explore how transepithelial permeability contributes to changes in the lung structure 
caused by antenatal steroid administration, but we would need to collect NECs from 
preterm infants delivered before antenatal steroids were administered or had time to 
work.  
 
As the airway epithelium acts as a barrier between the internal milieu and inhaled 
pathogens, it is susceptible to frequent injuries. Wound repair is imperative for the 
function of a healthy airway epithelium. Defective wound repair was observed with 
preterm NECs, taking a longer time overall to repair compared to their full-term 
counterparts. Defective wound repair is also seen in airway diseases like asthma 
(139), chronic obstructive pulmonary disease and cystic fibrosis (140). The inability 
to repair the airway epithelium in asthma (128) contributes to the functional defects 
seen in the disease setting (141). Interestingly, when BAL fluid, from preterm infants 
exposed to antenatal steroids were placed on wounded A549 cells in vitro, a faster 
rate of wound healing was observed compared to cells that were exposed to BAL 
fluid from preterm infants without steroid administration (142). The opposite was 
observed with infants exposed to chorioamniotis, with a decreased capability in 
wound healing. However, this study utilised an immortalised cell line originating 
from human lung carcinoma (143) and this may have altered the wound repair at 
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baseline. Immortalised cell lines are known to have increased proliferative capacity 
which can influence the rate of wound closure and is a factor to consider when 
interpreting these results. 
More severe consequences and longer time taken to heal from an infection from 
preterm infants could be attributed to defects seen in wound repair. A wide variance 
was observed in reparation of wounds in the preterm cohort. After assessment, 
wound repair rates were not correlated to gender, birth weight, GA, time on 
respiratory support or BPD diagnosis. Two out of the four preterm NECs that 
underwent wounding were exposed to chorioamniotis. When compared to their term 
counterparts, overall rate of repair was decreased. At 36 hours post wounding, 
wound closure for both chorioamniotis exposed infants were below 40%. This 
observed scale of repair was on the lower end of the spectrum for the preterm cohort. 
There is a defective repair process for some preterm infants compared to the full-
term cohort and wound repair is delayed overall. It is not known why a wide 
variance in wound healing capabilities is observed in preterm NECs. It can only be 
speculated that the disease progression of preterm children manifests at different 
rates and in certain individuals wound repair may not be defective but delayed.  
 
In summary, this chapter found that in comparison to full-term NECs, preterm NECs 
had lower transepithelial permeability which could suggest increased barrier 
integrity. Defective wound repair was also observed where preterm NECs either took 
a longer time to repair wounds or did not completely heal at the 72 hour time point. 
These two functional aspects may be somewhat interrelated. These findings suggest 
that as a result of defective wound repair, preterm NECs form tighter packed cellular 
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formations which mean smaller tight junctions reflecting a lower transepithelial 
permeability. Findings from this chapter confirm functional differences between full-
term and preterm NECs. A more sensitive method of culturing ALIs may need to be 
adopted to ensure a higher rate of culture success as culture failure was not 
correlated to birth weight, GA, gender, time on respiratory support and BPD 
diagnosis. A larger cohort is also needed in future studies to fully ascertain whether 
culture success is attributed to methodological limitations or due to other clinical 
factors. Larger numbers would then facilitate the ability to assess the extent of 


















Preterm infants are defined as those born before 37 completed weeks of gestation 
(13). The lungs are one of the last organs to develop in utero, therefore, the preterm 
lung is immature at birth, especially in those born at earlier gestational ages. Higher 
respiratory morbidity rates are experienced by preterm infants and in Australia, 61% 
of hospital admissions by preterm infants in the first year of life were respiratory 
related (18). Furthermore, preterm infants have reduced and declining lung function 
that persists into adolescence and been reported to have altered lung structure (48, 
50, 144, 145). These long term impacts on the lung imply potential changes in 
airway epithelial characteristics and or its barrier function (134) . However, no 
primary cell model of the preterm airway currently exists.  This project firstly aimed 
to and successfully developed a primary nasal epithelial cell culture model from 
preterm infants that was resultantly characterised. This study tested the hypothesis 
that very preterm born children (<32 weeks GA) are biochemically and functionally 
different to their full-term counterparts. Results did not completely support they 
hypothesis but there were a few substantial differences in the function of NECs that 
may have interesting implications for preterm respiratory disease.  
 
Preterm birth leads to a multi-faceted and diverse phenotypic spectrum. Many 
different pre and post-natal factors contribute to the variety of clinical presentations 
of preterm birth (1) including; the type of neonatal care, the type of respiratory 
support that is provided to the infant and co-morbidities such as BPD. Regardless, 
lower and declining lung function, altered lung structure and ongoing respiratory 
symptoms that persist into adolescence are common sequaele and we hypothesised 
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that intrinsic differences in their airway epithelium contribute to the ongoing 
morbidity.  
 
Primary cells were used to develop the model as it is the most reflective of the in 
vivo airway epithelium. Secondly, no immortalised cell lines from preterm infants 
are commercially available and thirdly an immortalised cell line would not have 
allowed for accurate representation of the wide range of clinical phenotypes resulting 
from preterm birth. Previous studies have shown through single cell 
microspectroscopy and proteomic phenotyping of cell lines and primary cells that 
cell lines have molecular differences to primary cells and may not be representative 
of cells in vivo (146-148). Importantly, there was no selection process with the 
collection of NECs from preterm infants which allowed us to analyse the full 
spectrum of clinical presentations from preterm birth and is an important first step 
for the characterisation of NECs from preterm infants. However this unbiased 
approach also led to a range of functional phenotypes that may have masked the 
significance of the findings with such a small dataset. 
 
Findings from this study were surprising given the high incidence of respiratory 
syncytial virus (RSV) infection in this cohort. We had presumed that the airway 
epithelium contributed to susceptibility to infection in addition to birth prior to 
maternal antibody transfer. Respiratory syncytial virus is a lower respiratory tract 
infection that targets the airway epithelium and infection often leads to 
hospitalisations particularly within the first two years of life in premature infants 
(149, 150). This could be attributed to the lack of maternal transfer of antibodies and 
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as a result preterm infants are born with an underdeveloped immune system with a 
predisposition for viral infections. At 32 weeks GA, the total fetal concentration of 
Immunoglobulin G is approximately only 50% of the mother’s (151). It has been 
shown that risk of RSV infection and severity is inversely correlated to age (152). A 
study comparing risk of RSV susceptibility in late preterm infants (34 - 36+6 weeks) 
compared to full-term infants observed that even late premature birth increases risk 
for RSV infection and hospitalisation (152). This suggests every week of gestation is 
crucial for individual developmental stages for the infant and being born severely 
underdeveloped can have major repercussions. The suggested underdevelopment of 
the airway epithelium can only be analysed in an in vitro model. 
 
Through in vitro culturing, possible intrinsic differences were assessed. Although 
mostly similar, there were some differences found in preterm NECs. Firstly, 
production of IL-8 at baseline was significantly higher in preterm NECs. Previous 
investigations have reported increased IL-8 production in venous cord blood (113) 
and BAL fluid (153) of preterm infants  that were found to correlate with 
mild/moderate BPD diagnosis. Interestingly, raised IL-8 has also been observed in 
sputum of adolescent children that have been born preterm (105). Collectively, the 
consistent observation of elevated IL-8 levels in preterm children, with and without 
BPD suggests that their airway epithelium is inherently more inflammatory than 
their full-term counterparts. This elevated inflammation may be a result of early life 
therapeutic treatments or BPD which translates to declined lung function that is seen 
later on in life (154, 155) although no studies are yet to explore this link or treat 
therapeutically.  
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Increased levels of IL-8 in infants with BPD over passage was observed, consistent 
with previous studies that observed persistent levels of this inflammatory cytokine 
present in respiratory fluids and cord blood (107, 156, 157). Apart from IL-8, no 
significant patterns were observed for gene expression and basal cytokine production 
in BPD and non-BPD phenotype. Results generated were from a small cohort and 
levels of gene and cytokine expression may be dependent on disease severity, 
infant’s age and the time when cells were sampled.  There is a lack of understanding 
of the mechanisms responsible for inter-individual differences in susceptibility and 
severity in BPD.  To fully understand the disease, it is crucial to know how these 
mechanisms interact. Previous characterisation of BPD have been functional, 
including assessing the structure of BPD diagnosed lung (55). Molecular 
characterisation has been through the use of amniotic fluid, respiratory fluids and 
cord blood (113, 114, 158). This project is the first to characterise BPD utilising the 
nasal epithelium. If feasible, future studies should use bronchial cells as they are still 
advocated to be the ‘gold standard’ for studying airway diseases and would be 
preferred in further characterisation of the BPD phenotype.  
 
It is still unknown why preterm infants suffer declining lung function and may be 
possibly attributed to lung immaturity, Immaturity in structure not only affects gas 
exchange but also had profound effects on the lung’s mechanical properties hence 
the respiratory system as a whole (43, 48). Although it has been suggested that the 
airway epithelium is immature, there is no current data to support this. Work 
conducted as part of this project found that CK-19 gene expression, an archetypal 
marker of mature epithelial cells was significantly higher in preterm NECs compared 
to full-term NECs. Furthermore, this upregulation was not reflected at the protein 
 128 
level. This aspect of characterisation is the first to be done in preterm infants and a 
discord between gene and protein levels were observed potentially signifying post 
transcriptional regulation (159-161). There is an unknown driver up-regulating CK-
19 and it was not reflected in protein production leads us to speculate that cells are in 
a state of immaturity and are therefore trying to mature, possibly catching up to their 
full-term counterparts. Could worse adverse reactions to viral infections and 
respiratory morbidity be attributed to this immaturity?  
 
An ALI model was successfully cultured using preterm NECs. Haemotoxylin & 
eosin stains of ALI sections showed that preterm NECs are not well differentiated 
though cilia was formed. This immaturity sustained by the cells may contribute to 
the observed defective and delayed wound repair. Interestingly, transepithelial 
permeability was higher in preterm NECs compared to their full-term counterparts. 
The preterm airway epithelium was assessed for its barrier integrity and was initially 
hypothesised to be ‘leakier’ than their full-term counterparts as shown by their 
vulnerability to frequent viral infections. In asthma, dysfunctional airway epithelial 
integrity is due to persistent inflammation and inefficient repair and regeneration into 
a fully differentiated and functional epithelium upon exposure to viruses and 
allergens (61, 141, 162). Dysregulated wound healing in addition to decreased 
barrier integrity contributes to asthma pathogenesis (128, 163). Defective wound 
repair was observed in the preterm NECs when compared to their full-term 
counterparts. This was an interesting observation and seemed to corroborate with 
findings of preterm children suffering worse consequences to viral infections 
requiring longer and more frequent periods of hospitalisations (18). However, 
increased barrier integrity was observed with defective wound repair in preterm 
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NECs. Increased barrier integrity is suggested to be a compensatory mechanism as a 
result of defective and delayed wound repair. As preterm infants have been often 
exposed to stressors such as mechanical ventilation and invasive ventilation 
strategies that can cause insult to the airway epithelium, these cells have upregulated 
their tight junction proteins as a result of their defective wound repair. 
 
Results from this study have shown that NECs from preterm children can be grown 
in an ALI model and used for functional assessment, future studies could use this 
model and expose cells to different oxygen environments and mimic a mechanical 
ventilation environment to simulate injury to preterm cells and assess wound repair 
under these various conditions. A previous study has found that inducing cystic 
fibrosis airway cells in a hypoxic state suppressed their innate immune function 
(164). In a murine model, under a hyperoxic setting for 24 hours, airway epithelial 
cells increased production of IL-17, a proinflammatory cytokine (165). Furthermore, 
in a time and dose dependent oxygen exposure experiment, airway epithelial cells 
were shown to increase pro-inflammatory cytokine release and decreased cell 
viability at 72 hours (166). Using an ALI model to infect epithelial cells with viruses 
and subsequently assessing wound repair is another aspect that can be studied. The 
ALI model is useful as it has been shown that certain viruses like Rhinovirus-C can 
only propagate in a differentiated cell (ALI) model and not in a submerged 
monolayer model (167).  
 
The findings of many similarities including overall cellular morphology, gene, 
protein and basal cytokine expression between NECs of full-term born and preterm 
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born children was contrary to the hypothesis and is suggestive of a number of things. 
Firstly, similar to findings of intrinsic differences in asthmatics (69), it may be that 
innate differences are restricted to the lower airway and not the nasal passage. 
Secondly, early life treatments like invasive mechanical ventilation, supplemental 
oxygen, postnatal surfactant and corticosteroid administration (168-170) are directed 
into the lower airway and may be where most of the predicted differences may be 
present. Thirdly, experiments in this study were conducted at baseline and not 
exposed to injurious pathogens. Adding to this, at time of sampling, children from 
both cohorts were non-symptomatic meaning NECs has a non-stimulated profile. If 
NECs were collected at time of an active infection, an elevated inflammatory 
cytokine profile would be observed. In cystic fibrosis, after virus infection, an 
increased production in inflammatory cytokines, IL-8 and IL-6, whilst at baseline 
diseased and healthy children had similar cytokine profiles (70). This could suggest 
that differences in the airway epithelial cells are only evident while exposed to a 
viral infection. Finally, a limited panel of cytokines and lineage markers were used 
to assess the airway epithelium of full-term and preterm born children. Other 
cytokines like anti-inflammatory and additional repair cytokines, additional lineage 
markers as well as the inclusion of tight junction proteins should be included in 
future analysis and may identify where molecular differences may exist. 
Interestingly, epigenetics can be studied in the context of preterm birth and may 
provide insight into the causes of expression of various genes. DNA methylation has 
been identified as an epigenetic change that is an epigenetic risk factor for preterm 
birth by causing cytosine methylation (171, 172). Specifically, 1555 sites with 
significant differences in methylation was observed between preterm and full-term 
infants at birth (173). A study by Cruikshank et al. 2013 showed the effects of 
 131 
epigenetic changes on gestational age of infant and in addition, showed persistent 
methylation differences between full-term and preterm infants (173). Similarly, 
Parets et al. 2013 found that a strong association between DNA methylation, preterm 
birth and infant’s gestational age (174). Profiling of full-term and preterm NECs 
through the use of ex vivo cells, RNA and protein lysates may highlight more 
differences between full-term and preterm epithelial cells. Though few differences 
were observed, they may be responsible for the functional differences observed in 
between full-term and preterm children. 
 
In other airway disease models like asthma and cystic fibrosis varied biochemical 
and functional differences have been found between healthy and disease states (175). 
In asthma, where cell characteristics like cellular morphology were similar to healthy 
children, intrinsic biochemical and functional differences, specifically increased 
proliferation rates, different expression of mature and basal cell markers and 
increased inflammatory cytokines were observed (69, 128). In cystic fibrosis, it has 
been observed that there are baseline similarities in inflammatory cytokines and 
markers between airway epithelial cells of healthy and diseased children, for 
example, it was the response to virus that revealed the airway of children with cystic 
fibrosis were hyper inflammatory and different to healthy children (70). In these 
different disease models, even though baseline characteristics of the airway 
epithelium were very similar, ultimately there were large functional differences that 
was proposed to contribute to the pathogenesis of the disease. Preterm children are 
still reported to have lower lung function than their full-term counterparts (49) and 
this may be a result of baseline differences in gene, protein and cytokine expression.  
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There was a wide spread of data that was generated from the preterm cohort. This 
highlights and reconfirms the heterogeneity of preterm ‘disease’. In the spread of 
data, there were two distinct groups observed in gene expression and basal cytokine 
production results which is suggestive of some sub-phenotypes within the preterm 
cohort. As shown in the data, there may be some hyper-inflammatory sub 
phenotypes compared to other low responders. This study also used a general 
population of preterm infants, which may attribute to the wide variance of data seen. 
Using a more selective population should be considered in the future when designing 
functional studies to address specific aspects of preterm airway disease. 
 
No significant correlations were observed when gender, gestational age, birth weight 
and time on respiratory support were investigated. A common way to stratify 
phenotypes in a preterm cohort is via BPD and non-BPD diagnosis. Similar to 
premature birth, BPD is a multi-factorial disease with many pre and postnatal factors 
influencing disease severity. It is also the most serious cause of morbidity in preterm 
infants (176). Bronchopulmonary dysplasia is in part indicated by an imbalance in 
pro and anti-inflammatory cytokines with persistence towards a more inflammatory 
state (154). Interestingly, upon stratification into BPD and non-BPD phenotypes, 
results were not clearly delineated and this study did not find significant correlations 
or patterns of cytokeratin and cytokine production were observed. 
Bronchopulmonary dysplasia is only defined if an infant has had oxygen for 28 days 
at 36 weeks post-menstrual age and how much oxygen was administered (25). 
Unlike findings from this study, many published studies have found differences in 
 133 
inflammatory profiles of BPD vs non-BPD children (154, 155, 157, 177). Numbers 
used in this study may be too small for any differences to be observed and a larger 
cohort with BPD survivors of different classifications is needed.  
 
Data generated in this projects also observed no differences in IL-6 were seen in full-
term and preterm born infants as well as between BPD and non-BPD phenotypes. 
Interleukin-6 is a marker of acute inflammation and has been observed in tracheal 
aspirates of preterm infants that subsequently developed BPD in the first 3 days after 
birth (156). Levels of IL-6 were found to be significantly elevated compared to 
infants who did not develop BPD. Similarly, Kotecha et al. 1996 found increased 
levels of IL-1β and IL-6 in BAL fluid of infants that developed BPD (117). Yoon et 
al. 1995 also found significantly higher concentrations of pro-inflammatory 
cytokines IL-1β, IL-8, IL-6 and tumour necrosis factor-α in the amniotic fluid of 
mothers that delivered infants that developed BPD (178). As the study cohort size 
may have been small and samples were not collected at a time of acute virus 
infection, IL-6 levels were similar between cohorts.   
 
Persistent inflammation is present in children with BPD. Furthermore, there is 
suggestion that this may reflect an inability to regulate inflammation through anti-
inflammatory mediators including IL-4 and IL-13. Interestingly, a study by Baier et 
al. 2003 found that the anti-inflammatory cytokines IL-4 and IL-13 were not 
significantly elevated in infants developing BPD (179) indicating either a defective 
or delayed anti-inflammatory response. Similarly, a study by Jones et al. 1996 
observed undetectable levels of IL-10, another anti-inflammatory cytokine, in BAL 
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fluid taken at 24 hours after birth of preterm infants with acute respiratory failure, 
whilst IL-10 was present in BAL from their full-term counterparts (180). However, 
another study showed detectable levels of IL-10 in BAL fluid of preterm infants 
ventilated for RDS at 96 hours after birth (106). It has been hypothesised that the 
ability to produce IL-10 is developmentally regulated therefore correlated to the 
infant’s gestational age. Contrasting results from these studies could also be due to 
the technicalities of sample collection and processing as well as sensitivity of the 
ELISA kits used. Production levels of anti-inflammatory cytokines i.e. IL-4, 10, 13, 
should be measured at baseline and after a viral infection to ascertain if differences 
are present between full-term and preterm NECs. This study aimed to characterise 
NECs of preterm children at an unstimulated baseline but future studies could test 
the adaptive response to stimuli particularly viruses of preterm children.  
 
This study is the first of its kind providing insights into the airway epithelium of very 
preterm born infants. However, there were limitations identified that future studies 
should consider. Firstly, this study utilised a relatively small sample size and non-
selective inclusion criteria. Thus, to ascertain more differences as well as their 
extent, a larger cohort may be required. Secondly, it is acknowledged that NECs 
obtained from preterm infants were approximately a year younger than NECs 
obtained from full-term children. Although it is uncertain whether age plays a role in 
changing the biochemistry of the airway epithelium, no significant correlations were 
found between the age of infants used in this investigation and gene and cytokine 
results generated.  
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Due to ethical limitations, nasal epithelial cells were utilised for this characterisation 
study and not bronchial airway epithelial cells. Though there have been studies that 
have investigated the feasibility of using NECs as a surrogate for bronchial airway 
epithelial cells to study respiratory illnesses (72, 73, 181), there may be some 
differences in the lower airway that is not reflected in the nasal passage. Findings 
from Pringle et al. 2012 were contrasting and found differences in IL-6, IL-8 and 
Granulyte Colony Stimulating Factor (G-CSF) from nasal and bronchial cells (182). 
Therefore, bronchial airway epithelial cells were still advocated to be the gold 
standard for cell culture model to study respiratory illnesses (183). Given ethics 
permission, future studies should use bronchial airway epithelial cells to ascertain 
biochemical and functional differences between full-term and preterm children. We 
only cultured preterm NECs that were able to be grown in vitro. There were samples 
that weren’t able to be established even using conditional reprogramming suggesting 
their highly vulnerable state. The inability to culture these preterm NECs suggests 
we have not captured the full range of preterm phenotypes. In order to address this, 
RNA and protein lysate samples generated from ex vivo samples could be assessed 
for differences using transcriptomics. RNA sequencing allows for high throughput 
analysis of individual genomes. Through the use of transcriptomics, the human 
genome has started to be characterised and cells from a murine model have been 
successfully characterised (184, 185).  
 
Although no gross differences were observed between full-term and preterm NECs, 
this study did not assess cell responses to infectious pathogens. Viral infections from 
RSV and human rhinovirus (HRV) are the leading causes of hospitalisation of 
preterm infants in the first year of life (18, 186). It may be a preterm infant’s aberrant 
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response to pathogens including viruses and pathogens which may differ between 
them and full-term infants. Hyper inflammatory responses of the airway epithelium 
have previously been observed when bronchial cells from subjects with cystic 
fibrosis were infected by bacteria or viruses (70). Future studies should assess the 
inflammatory profile of airway epithelial cells after infection with HRV and/or RSV 
In addition, it would be of interest to measure the inflammatory profiles after 
infection with HRV and RSV individually and then together as co-infections are 
known to occur in this cohort (186). Measurement of a panel of cytokines and 
chemokines via the use of a Cytokine Human Magnetic 25-Plex Panel will be a fast 
and efficient way to identify key players such as, IL-6, IL-8, IP-10, RANTES in the 
inflammation process (187, 188). Using flow cytometry, cells can be sorted and 
apoptotic or necrotic cell profiles can also be analysed. Informative examples from 
other diseases include asthma and cystic fibrosis where viral infection to airway 
epithelial cells trigger a hyper-inflammatory response typically seen with a deficient 
anti-inflammatory response (70, 187, 189). 
 
In conclusion, this is the first detailed and comprehensive study characterising nasal 
epithelial cells of preterm infants at basal state. This study has firstly successfully 
established NEC cultures from a non-selective cohort of preterm infants and 
successfully cultured the NECs till passage 3 for experimental purposes. 
Characterisation of NECs have shown that NECs are similar in full-term and preterm 
born children, though these similarities may be region specific. However, some 
differences have been identified including; increased barrier integrity, defective 
wound repair and a number of biochemical differences at baseline suggesting that 
these cells are somewhat intrinsically different. These differences has assisted in 
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understanding the effects of prematurity on the airway epithelium and justify future 
investigations in this area.  
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